00000387779/302025Q1FALSExbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureben:CIPs00000387772024-10-012024-12-3100000387772025-01-230000038777us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2024-10-012024-12-310000038777us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2023-10-012023-12-310000038777ben:SalesAndDistributionFeesMember2024-10-012024-12-310000038777ben:SalesAndDistributionFeesMember2023-10-012023-12-310000038777us-gaap:ShareholderServiceMember2024-10-012024-12-310000038777us-gaap:ShareholderServiceMember2023-10-012023-12-310000038777us-gaap:ServiceOtherMember2024-10-012024-12-310000038777us-gaap:ServiceOtherMember2023-10-012023-12-3100000387772023-10-012023-12-310000038777ben:ConsolidatedInvestmentProductsMember2024-10-012024-12-310000038777ben:ConsolidatedInvestmentProductsMember2023-10-012023-12-310000038777ben:FranklinResourcesInc.Member2024-12-310000038777ben:FranklinResourcesInc.Member2024-09-3000000387772024-12-3100000387772024-09-300000038777ben:ConsolidatedInvestmentProductsMember2024-12-310000038777ben:ConsolidatedInvestmentProductsMember2024-09-300000038777us-gaap:CommonStockMember2024-09-300000038777us-gaap:AdditionalPaidInCapitalMember2024-09-300000038777us-gaap:RetainedEarningsMember2024-09-300000038777us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300000038777us-gaap:ParentMember2024-09-300000038777us-gaap:NoncontrollingInterestMember2024-09-300000038777us-gaap:RetainedEarningsMember2024-10-012024-12-310000038777us-gaap:ParentMember2024-10-012024-12-310000038777us-gaap:NoncontrollingInterestMember2024-10-012024-12-310000038777us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310000038777us-gaap:CommonStockMember2024-10-012024-12-310000038777us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310000038777us-gaap:CommonStockMember2024-12-310000038777us-gaap:AdditionalPaidInCapitalMember2024-12-310000038777us-gaap:RetainedEarningsMember2024-12-310000038777us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000038777us-gaap:ParentMember2024-12-310000038777us-gaap:NoncontrollingInterestMember2024-12-310000038777us-gaap:CommonStockMember2023-09-300000038777us-gaap:AdditionalPaidInCapitalMember2023-09-300000038777us-gaap:RetainedEarningsMember2023-09-300000038777us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000038777us-gaap:ParentMember2023-09-300000038777us-gaap:NoncontrollingInterestMember2023-09-3000000387772023-09-300000038777us-gaap:RetainedEarningsMember2023-10-012023-12-310000038777us-gaap:ParentMember2023-10-012023-12-310000038777us-gaap:NoncontrollingInterestMember2023-10-012023-12-310000038777us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310000038777us-gaap:CommonStockMember2023-10-012023-12-310000038777us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310000038777us-gaap:CommonStockMember2023-12-310000038777us-gaap:AdditionalPaidInCapitalMember2023-12-310000038777us-gaap:RetainedEarningsMember2023-12-310000038777us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000038777us-gaap:ParentMember2023-12-310000038777us-gaap:NoncontrollingInterestMember2023-12-3100000387772023-12-310000038777country:USus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2024-10-012024-12-310000038777country:LUus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2024-10-012024-12-310000038777srt:AsiaPacificMemberus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2024-10-012024-12-310000038777ben:AmericasExcludingUnitedStatesMemberus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2024-10-012024-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMemberus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2024-10-012024-12-310000038777country:USben:SalesAndDistributionFeesMember2024-10-012024-12-310000038777country:LUben:SalesAndDistributionFeesMember2024-10-012024-12-310000038777srt:AsiaPacificMemberben:SalesAndDistributionFeesMember2024-10-012024-12-310000038777ben:AmericasExcludingUnitedStatesMemberben:SalesAndDistributionFeesMember2024-10-012024-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMemberben:SalesAndDistributionFeesMember2024-10-012024-12-310000038777country:USus-gaap:ShareholderServiceMember2024-10-012024-12-310000038777country:LUus-gaap:ShareholderServiceMember2024-10-012024-12-310000038777srt:AsiaPacificMemberus-gaap:ShareholderServiceMember2024-10-012024-12-310000038777ben:AmericasExcludingUnitedStatesMemberus-gaap:ShareholderServiceMember2024-10-012024-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMemberus-gaap:ShareholderServiceMember2024-10-012024-12-310000038777country:USus-gaap:ServiceOtherMember2024-10-012024-12-310000038777country:LUus-gaap:ServiceOtherMember2024-10-012024-12-310000038777srt:AsiaPacificMemberus-gaap:ServiceOtherMember2024-10-012024-12-310000038777ben:AmericasExcludingUnitedStatesMemberus-gaap:ServiceOtherMember2024-10-012024-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMemberus-gaap:ServiceOtherMember2024-10-012024-12-310000038777country:US2024-10-012024-12-310000038777country:LU2024-10-012024-12-310000038777srt:AsiaPacificMember2024-10-012024-12-310000038777ben:AmericasExcludingUnitedStatesMember2024-10-012024-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMember2024-10-012024-12-310000038777country:USus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2023-10-012023-12-310000038777country:LUus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2023-10-012023-12-310000038777srt:AsiaPacificMemberus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2023-10-012023-12-310000038777ben:AmericasExcludingUnitedStatesMemberus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2023-10-012023-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMemberus-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember2023-10-012023-12-310000038777country:USben:SalesAndDistributionFeesMember2023-10-012023-12-310000038777country:LUben:SalesAndDistributionFeesMember2023-10-012023-12-310000038777srt:AsiaPacificMemberben:SalesAndDistributionFeesMember2023-10-012023-12-310000038777ben:AmericasExcludingUnitedStatesMemberben:SalesAndDistributionFeesMember2023-10-012023-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMemberben:SalesAndDistributionFeesMember2023-10-012023-12-310000038777country:USus-gaap:ShareholderServiceMember2023-10-012023-12-310000038777country:LUus-gaap:ShareholderServiceMember2023-10-012023-12-310000038777srt:AsiaPacificMemberus-gaap:ShareholderServiceMember2023-10-012023-12-310000038777ben:AmericasExcludingUnitedStatesMemberus-gaap:ShareholderServiceMember2023-10-012023-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMemberus-gaap:ShareholderServiceMember2023-10-012023-12-310000038777country:USus-gaap:ServiceOtherMember2023-10-012023-12-310000038777country:LUus-gaap:ServiceOtherMember2023-10-012023-12-310000038777srt:AsiaPacificMemberus-gaap:ServiceOtherMember2023-10-012023-12-310000038777ben:AmericasExcludingUnitedStatesMemberus-gaap:ServiceOtherMember2023-10-012023-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMemberus-gaap:ServiceOtherMember2023-10-012023-12-310000038777country:US2023-10-012023-12-310000038777country:LU2023-10-012023-12-310000038777srt:AsiaPacificMember2023-10-012023-12-310000038777ben:AmericasExcludingUnitedStatesMember2023-10-012023-12-310000038777ben:EuropeMiddleEastandAfricaExcludingLuxembourgMember2023-10-012023-12-310000038777ben:SponsoredFundsAndSeparateAccountsMember2024-12-310000038777ben:SponsoredFundsAndSeparateAccountsMember2024-09-300000038777ben:LongTermIncentiveCompensationPlansMember2024-12-310000038777ben:LongTermIncentiveCompensationPlansMember2024-09-300000038777ben:DebtAndEquitySecuritiesMember2024-12-310000038777ben:DebtAndEquitySecuritiesMember2024-09-300000038777us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-12-310000038777us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-12-310000038777us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-12-310000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-12-310000038777us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-12-310000038777us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-12-310000038777us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-12-310000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-12-310000038777us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-12-310000038777us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-12-310000038777us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-12-310000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-09-300000038777us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-09-300000038777us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-09-300000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberben:SponsoredFundsAndSeparateAccountsMember2024-09-300000038777us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-09-300000038777us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-09-300000038777us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-09-300000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberben:LongTermIncentiveCompensationPlansMember2024-09-300000038777us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-09-300000038777us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-09-300000038777us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-09-300000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberben:DebtAndEquitySecuritiesMember2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:NonredeemableFundsWithKnownLiquidationPeriodsMember2024-12-310000038777ben:NonredeemableFundsWithKnownLiquidationPeriodsMember2024-09-300000038777ben:NonredeemableFundsWithUnknownLiquidationPeriodsMember2024-12-310000038777ben:NonredeemableFundsWithUnknownLiquidationPeriodsMember2024-09-300000038777ben:RedeemableFundsMember2024-12-310000038777ben:RedeemableFundsMember2024-09-300000038777ben:NonredeemableFundsWithKnownLiquidationPeriodsMember2023-10-012024-09-300000038777ben:NonredeemableFundsWithKnownLiquidationPeriodsMember2024-10-012024-12-310000038777us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310000038777us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2024-12-310000038777us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300000038777us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2024-09-300000038777us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2024-12-310000038777us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2024-09-300000038777us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2024-12-310000038777us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2024-12-310000038777us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2024-09-300000038777us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2024-09-300000038777us-gaap:FairValueInputsLevel1Memberus-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueInputsLevel2Memberus-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel1Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel2Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel1Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel2Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:LoansReceivableMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:LoansReceivableMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueInputsLevel1Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueInputsLevel2Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777us-gaap:FairValueMeasurementsRecurringMemberben:ConsolidatedInvestmentProductsMember2024-12-310000038777us-gaap:FairValueInputsLevel1Memberus-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueInputsLevel2Memberus-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel1Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel2Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel1Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel2Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:LoansReceivableMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:LoansReceivableMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueInputsLevel1Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueInputsLevel2Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:FairValueMeasurementsRecurringMemberben:ConsolidatedInvestmentProductsMember2024-09-300000038777ben:NonredeemableFundsWithUnknownLiquidationPeriodsMemberben:ConsolidatedInvestmentProductsMember2024-12-310000038777ben:NonredeemableFundsWithUnknownLiquidationPeriodsMemberben:ConsolidatedInvestmentProductsMember2024-09-300000038777ben:RedeemableFundsMemberben:ConsolidatedInvestmentProductsMember2024-12-310000038777ben:RedeemableFundsMemberben:ConsolidatedInvestmentProductsMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2024-10-012024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-09-300000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-09-300000038777us-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-10-012023-12-310000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-10-012023-12-310000038777us-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-10-012023-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-12-310000038777us-gaap:LoansReceivableMemberus-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-12-310000038777us-gaap:FairValueInputsLevel3Memberben:ConsolidatedInvestmentProductsMember2023-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputQuotedPriceMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputQuotedPriceMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputQuotedPriceMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:IncomeApproachValuationTechniqueMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:IncomeApproachValuationTechniqueMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:IncomeApproachValuationTechniqueMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:IncomeApproachValuationTechniqueMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputQuotedPriceMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputQuotedPriceMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputQuotedPriceMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:MinimumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:MaximumMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberben:MarketPricingValuationApproachMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:IncomeApproachValuationTechniqueMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777ben:DebtAndEquitySecuritiesMemberus-gaap:IncomeApproachValuationTechniqueMembersrt:WeightedAverageMemberben:ConsolidatedInvestmentProductsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000038777us-gaap:CarryingReportedAmountFairValueDisclosureMemberben:ConsolidatedInvestmentProductsMember2024-12-310000038777us-gaap:FairValueInputsLevel1Memberben:ConsolidatedInvestmentProductsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310000038777us-gaap:CarryingReportedAmountFairValueDisclosureMemberben:ConsolidatedInvestmentProductsMember2024-09-300000038777us-gaap:FairValueInputsLevel1Memberben:ConsolidatedInvestmentProductsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300000038777us-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310000038777us-gaap:FairValueInputsLevel2Memberus-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310000038777us-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300000038777us-gaap:FairValueInputsLevel2Memberus-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300000038777us-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMember2024-12-310000038777us-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMember2024-09-300000038777srt:MinimumMemberus-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMember2024-12-310000038777srt:MaximumMemberus-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMember2024-12-310000038777srt:MinimumMemberus-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMember2024-09-300000038777srt:MaximumMemberus-gaap:CollateralizedLoanObligationsMemberben:ConsolidatedInvestmentProductsMember2024-09-300000038777ben:ConsolidatedInvestmentProductsMember2024-12-310000038777us-gaap:CollateralizedLoanObligationsMember2024-12-310000038777us-gaap:CollateralizedLoanObligationsMember2024-09-300000038777us-gaap:CollateralizedLoanObligationsMember2024-10-012024-12-310000038777us-gaap:CollateralizedLoanObligationsMember2023-10-012023-12-310000038777ben:MinorityInterestsMember2024-09-300000038777ben:RedeemableNoncontrollingInterestMember2024-09-300000038777ben:ConsolidatedInvestmentProductsMember2023-09-300000038777ben:MinorityInterestsMember2023-09-300000038777ben:RedeemableNoncontrollingInterestMember2023-09-300000038777ben:MinorityInterestsMember2024-10-012024-12-310000038777ben:RedeemableNoncontrollingInterestMember2024-10-012024-12-310000038777ben:MinorityInterestsMember2023-10-012023-12-310000038777ben:RedeemableNoncontrollingInterestMember2023-10-012023-12-310000038777ben:MinorityInterestsMember2024-12-310000038777ben:RedeemableNoncontrollingInterestMember2024-12-310000038777ben:ConsolidatedInvestmentProductsMember2023-12-310000038777ben:MinorityInterestsMember2023-12-310000038777ben:RedeemableNoncontrollingInterestMember2023-12-310000038777us-gaap:InvestmentsMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-12-310000038777us-gaap:InvestmentsMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-09-300000038777us-gaap:TradeAccountsReceivableMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-12-310000038777us-gaap:TradeAccountsReceivableMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-09-300000038777us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-12-310000038777us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-09-300000038777ben:TimeBasedSharesMember2024-09-300000038777us-gaap:PerformanceSharesMember2024-09-300000038777ben:TimeBasedSharesMember2024-10-012024-12-310000038777us-gaap:PerformanceSharesMember2024-10-012024-12-310000038777ben:TimeBasedSharesMember2024-12-310000038777us-gaap:PerformanceSharesMember2024-12-31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(MARK ONE)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2024
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission File Number: 001-09318
FRANKLIN RESOURCES, INC.
(Exact name of registrant as specified in its charter)
Delaware13-2670991
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)

One Franklin Parkway, San Mateo, CA 94403
(Address of principal executive offices) (Zip code)

(650) 312-2000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, par value $0.10 per shareBENNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      Yes      No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).      Yes      No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated Filer
Non-accelerated Filer
Smaller Reporting Company
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act).    
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes      No
Number of shares of the registrant’s common stock outstanding at January 23, 2025: 525,397,977.



INDEX TO FORM 10-Q

2

PART I – FINANCIAL INFORMATION
Item 1. Financial Statements.

FRANKLIN RESOURCES, INC.
CONSOLIDATED STATEMENTS OF INCOME
Unaudited
 
Three Months Ended
December 31,
(in millions, except per share data)20242023
Operating Revenues
Investment management fees$1,799.3 $1,652.2 
Sales and distribution fees375.5 296.4 
Shareholder servicing fees63.5 32.5 
Other13.3 10.0 
Total operating revenues2,251.6 1,991.1 
Operating Expenses
Compensation and benefits991.4 968.3 
Sales, distribution and marketing512.3 400.8 
Information systems and technology156.0 131.0 
Occupancy75.1 66.7 
Amortization of intangible assets112.6 85.8 
General, administrative and other185.2 132.0 
Total operating expenses2,032.6 1,784.6 
Operating Income219.0 206.5 
Other Income (Expenses)
Investment and other income, net10.5 173.2 
Interest expense(23.1)(18.8)
Investment and other income (losses) of consolidated investment products, net114.1 (23.8)
Expenses of consolidated investment products(7.3)(5.9)
Other income, net94.2 124.7 
Income before taxes313.2 331.2 
Taxes on income81.1 74.9 
Net income232.1 256.3 
Less: net income (loss) attributable to
Redeemable noncontrolling interests49.6 9.5 
Nonredeemable noncontrolling interests18.9 (4.5)
Net Income Attributable to Franklin Resources, Inc.$163.6 $251.3 
Earnings per Share
Basic$0.29 $0.50 
Diluted0.29 0.50 

See Notes to Consolidated Financial Statements.

3

FRANKLIN RESOURCES, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Unaudited
(in millions)Three Months Ended
December 31,
20242023
Net Income$232.1 $256.3 
Other Comprehensive Income (Loss)
Currency translation adjustments, net of tax(105.1)59.1 
Net unrealized gains (losses) on defined benefit plans, net of tax0.3 (0.1)
Total other comprehensive income (loss)(104.8)59.0 
Total comprehensive income127.3 315.3 
Less: comprehensive income (loss) attributable to
Redeemable noncontrolling interests49.6 9.5 
Nonredeemable noncontrolling interests18.9 (4.5)
Comprehensive Income Attributable to Franklin Resources, Inc.$58.8 $310.3 

See Notes to Consolidated Financial Statements.

4

FRANKLIN RESOURCES, INC.
CONSOLIDATED BALANCE SHEETS
Unaudited
(in millions, except share and per share data)December 31,
2024
September 30,
2024
Assets
Cash and cash equivalents$2,808.0 $3,309.5 
Receivables1,393.8 1,479.1 
Investments (including $806.9 and $838.0 at fair value at December 31, 2024 and September 30, 2024)
2,392.5 2,338.4 
Assets of consolidated investment products
Cash and cash equivalents837.1 1,099.4 
Investments, at fair value11,897.4 11,034.9 
Property and equipment, net977.7 946.4 
Goodwill6,193.9 6,211.4 
Intangible assets, net4,677.3 4,802.1 
Operating lease right-of-use assets795.1 823.3 
Other417.2 420.0 
Total Assets$32,390.0 $32,464.5 
Liabilities
Compensation and benefits$1,131.8 $1,801.3 
Accounts payable and accrued expenses585.0 551.5 
Income taxes461.4 406.4 
Debt2,775.8 2,780.3 
Liabilities of consolidated investment products
Accounts payable and accrued expenses861.2 861.3 
Debt9,055.3 9,341.5 
Deferred tax liabilities279.8 284.9 
Operating lease liabilities946.2 965.1 
Other953.8 907.4 
Total liabilities17,050.3 17,899.7 
Commitments and Contingencies (Note 10)
Redeemable Noncontrolling Interests2,106.0 1,321.8 
Stockholders’ Equity
Preferred stock, $1.00 par value, 1,000,000 shares authorized; none issued
  
Common stock, $0.10 par value, 1,000,000,000 shares authorized; 523,967,899 and 523,596,548 shares issued and outstanding at December 31, 2024 and September 30, 2024
52.4 52.4 
Capital in excess of par
1,014.9 947.6 
Retained earnings11,919.1 11,927.6 
Accumulated other comprehensive loss(524.3)(419.5)
Total Franklin Resources, Inc. stockholders’ equity12,462.1 12,508.1 
Nonredeemable noncontrolling interests771.6 734.9 
Total stockholders’ equity13,233.7 13,243.0 
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity$32,390.0 $32,464.5 

See Notes to Consolidated Financial Statements.

5

FRANKLIN RESOURCES, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
Unaudited
Franklin Resources, Inc.Non-
redeemable
Non-
controlling
Interests
Total
Stockholders’
Equity
Common StockCapital
in
Excess
of Par
Value
Retained
Earnings
Accum-
ulated
Other
Compre-
hensive
Loss
Stockholders’
Equity
(in millions)
for the three months ended
December 31, 2024
SharesAmount
Balance at October 1, 2024523.6 $52.4 $947.6 $11,927.6 $(419.5)$12,508.1 $734.9 $13,243.0 
Net income163.6 163.6 18.9 182.5 
Other comprehensive loss(104.8)(104.8)(104.8)
Dividends declared on common stock ($0.32 per share)
(173.6)(173.6)(173.6)
Repurchase of common stock
(0.3) (5.8) (5.8)(5.8)
Issuance of common stock
0.7  21.5 21.5 21.5 
Stock-based compensation
51.6 51.6 51.6 
Net subscriptions and other13.1 13.1 
Net consolidation of investment products4.7 4.7 
Adjustment to fair value of redeemable noncontrolling interests1.5 1.5 1.5 
Balance at December 31, 2024524.0 $52.4 $1,014.9 $11,919.1 $(524.3)$12,462.1 $771.6 $13,233.7 

Franklin Resources, Inc.Non-
redeemable
Non-
controlling
Interests
Total
Stockholders’
Equity
Common StockCapital
in
Excess
of Par
Value
Retained
Earnings
Accum-
ulated
Other
Compre-
hensive
Loss
Stockholders’
Equity
(in millions)
for the three months ended
December 31, 2023
SharesAmount
Balance at October 1, 2023495.9 $49.6 $ $12,376.6 $(509.3)$11,916.9 $630.9 $12,547.8 
Net income (loss)251.3 251.3 (4.5)246.8 
Other comprehensive income59.0 59.0 59.0 
Dividends declared on common stock ($0.31 per share)
(167.6)(167.6)(167.6)
Repurchase of common stock(2.4)(0.2)(66.6)8.0 (58.8)(58.8)
Issuance of common stock1.2 0.1 26.7 26.8 26.8 
Stock-based compensation39.9 39.9 39.9 
Net subscriptions and other9.6 9.6 
Adjustment to fair value of redeemable noncontrolling interests
(65.9)(65.9)(65.9)
Balance at December 31, 2023494.7 $49.5 $ $12,402.4 $(450.3)$12,001.6 $636.0 $12,637.6 
See Notes to Consolidated Financial Statements.

6


FRANKLIN RESOURCES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Unaudited
 
Three Months Ended
December 31,
(in millions)20242023
Net Income$232.1 $256.3 
Adjustments to reconcile net income to net cash used in operating activities:
Stock-based compensation73.2 66.8 
Amortization of deferred sales commissions20.2 13.4 
Depreciation and other amortization30.2 25.7 
Amortization of intangible assets112.6 85.8 
Net losses (gains) on investments57.1 (60.1)
Losses (income) from investments in equity method investees7.6 (56.9)
Net (gains) losses on investments of consolidated investment products(87.2)66.0 
Net purchase of investments by consolidated investment products(83.9)(147.5)
Deferred income taxes1.6 (57.7)
Other31.6 31.6 
Changes in operating assets and liabilities:
Decrease (increase) in receivables and other assets10.2 (36.7)
Decrease in investments, net1.1 0.2 
Decrease in accrued compensation and benefits(654.3)(508.0)
Increase in income taxes payable55.0 107.9 
Increase (decrease) in accounts payable, accrued expenses and other liabilities95.0 (39.7)
Increase (decrease) in accounts payable and accrued expenses of consolidated investment products(47.3)1.0 
Net cash used in operating activities(145.2)(251.9)
Purchase of investments(458.0)(267.4)
Liquidation of investments168.4 317.6 
Purchase of investments by consolidated collateralized loan obligations(1,291.1)(794.0)
Liquidation of investments by consolidated collateralized loan obligations1,001.1 697.0 
Additions of property and equipment, net(71.8)(19.5)
Payments of deferred consideration liability (60.8)
Net deconsolidation of investment products(5.1)(10.5)
Net cash used in investing activities(656.5)(137.6)
[Table continued on next page]

See Notes to Consolidated Financial Statements.

7


FRANKLIN RESOURCES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Unaudited
[Table continued from previous page]
 
Three Months Ended
December 31,
(in millions)20242023
Dividends paid on common stock$(166.2)$(155.7)
Repurchase of common stock(5.8)(58.8)
Proceeds from repurchase agreement38.9  
Payments on repurchase agreement
(29.6) 
Proceeds from debt of consolidated investment products794.4 39.8 
Payments on debt of consolidated investment products(714.9)(22.0)
Payments on contingent consideration liabilities(0.7) 
Noncontrolling interests171.8 37.7 
Net cash provided by (used in) financing activities87.9 (159.0)
Effect of exchange rate changes on cash and cash equivalents(50.0)25.7 
Decrease in cash and cash equivalents(763.8)(522.8)
Cash and cash equivalents, beginning of period4,408.9 4,402.4 
Cash and Cash Equivalents, End of Period$3,645.1 $3,879.6 
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes$27.9 $26.8 
Cash paid for interest9.9 10.6 
Cash paid for interest by consolidated investment products
202.0 161.6 

See Notes to Consolidated Financial Statements.

8

FRANKLIN RESOURCES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2024
(Unaudited)
Note 1 Basis of Presentation
The unaudited interim financial statements of Franklin Resources, Inc. (“Franklin”) and its consolidated subsidiaries (collectively, the “Company”) included herein have been prepared in accordance with the instructions to Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Under these rules and regulations, some information and footnote disclosures normally included in financial statements prepared under accounting principles generally accepted in the United States of America have been shortened or omitted. Management believes that all adjustments necessary for a fair statement of the financial position and the results of operations for the periods shown have been made. All adjustments are normal and recurring. Management also believes that the accounting estimates are appropriate, and the resulting balances are reasonable; however, due to the inherent uncertainties in making estimates, actual amounts may differ from these estimates. These financial statements should be read together with the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2024 (“fiscal year 2024”).
Note 2 New Accounting Guidance
Accounting Guidance Not Yet Adopted
In November 2023, the Financial Accounting Standards Board (“FASB”) issued an amendment to the existing segment reporting guidance. The amendment requires annual and interim disclosures of significant segment expenses that are regularly provided to the chief operating decision maker by reportable segment and clarifies that single reportable segment entities are required to apply all existing segment disclosures in the guidance. The Company will adopt the annual disclosures in its Annual Report on Form 10-K for the fiscal year ending September 30, 2025 and interim disclosure in its Quarterly report on Form 10-Q for the quarter ending December 31, 2025.
There were no other significant updates to the new accounting guidance that the Company has not yet adopted as disclosed in its Form 10-K for fiscal year 2024.
Note 3 Earnings per Share
The components of basic and diluted earnings per share were as follows: 
(in millions, except per share data)
Three Months Ended
December 31,
20242023
Net income attributable to Franklin Resources, Inc.$163.6 $251.3 
Less: allocation of earnings to participating nonvested stock and stock unit awards
15.4 9.7 
Net Income Available to Common Stockholders$148.2 $241.6 
Weighted-average shares outstanding – basic517.4 487.0 
Dilutive effect of nonparticipating nonvested stock unit awards
0.8 0.9 
Weighted-Average Shares Outstanding – Diluted518.2 487.9 
Earnings per Share
Basic$0.29 $0.50 
Diluted0.29 0.50 
There were no nonparticipating nonvested stock unit awards excluded from the calculation of diluted earnings per share because their effect would have been antidilutive for the three months ended December 31, 2024 and such awards were insignificant for the three months ended December 31, 2023.
9

Note 4 Revenues
Operating revenues by geographic area were as follows:
(in millions)United StatesLuxembourgAsia-PacificAmericas
Excluding
United
States
Europe,
Middle East
and Africa,
Excluding
Luxembourg
Total
for the three months ended December 31, 2024
Investment management fees
$1,361.4 $223.9 $75.8 $53.6 $84.6 $1,799.3 
Sales and distribution fees
267.1 93.4 4.9 10.0 0.1 375.5 
Shareholder servicing fees
55.1 8.0 0.4   63.5 
Other
13.1  0.2   13.3 
Total
$1,696.7 $325.3 $81.3 $63.6 $84.7 $2,251.6 
(in millions)United StatesLuxembourgAsia-PacificAmericas
Excluding
United
States
Europe,
Middle East
and Africa,
Excluding
Luxembourg
Total
for the three months ended December 31, 2023
Investment management fees
$1,260.6 $191.7 $68.5 $51.5 $79.9 $1,652.2 
Sales and distribution fees
205.7 76.5 4.6 9.6  296.4 
Shareholder servicing fees
24.2 7.6 0.6 0.1  32.5 
Other
9.0 0.5 0.2  0.3 10.0 
Total
$1,499.5 $276.3 $73.9 $61.2 $80.2 $1,991.1 
Operating revenues are attributed to geographic areas based on the locations of the subsidiaries that provide the services, which may differ from the regions in which the related investment products are sold.
Revenues earned from sponsored funds were 83% of the Company’s total operating revenues for the three months ended December 31, 2024 and 2023.
Note 5 Investments
The disclosures below include details of the Company’s investments, excluding those of consolidated investment products (“CIPs”). See Note 7 Consolidated Investment Products for information related to the investments held by these entities.
Investments consisted of the following:
(in millions)December 31,
2024
September 30,
2024
Investments, at fair value
Sponsored funds and separate accounts$469.1 $509.1 
Investments related to long-term incentive plans266.3 271.6 
Other equity and debt investments71.5 57.3 
Total investments, at fair value806.9 838.0 
Investments in equity method investees1,175.5 1,219.7 
Other investments410.1 280.7 
Total$2,392.5 $2,338.4 
The Company has entered into repurchase agreements with a third-party financing company for certain investments held by the Company. As of December 31, 2024 and September 30, 2024, other liabilities includes repurchase agreements of $116.5 million and $111.4 million with investments of $122.5 million and $121.7 million in carrying value pledged as collateral. The repurchase agreements have contractual maturity dates ranging between 2030 to 2038.
10

Note 6 Fair Value Measurements
The disclosures below include details of the Company’s fair value measurements, excluding those of CIPs. See Note 7 – Consolidated Investment Products for information related to fair value measurements of the assets and liabilities of these entities.
The assets and liabilities measured at fair value on a recurring basis were as follows: 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of December 31, 2024
Assets
Investments, at fair value
Sponsored funds and separate accounts$257.6 $171.3 $4.7 $35.5 $469.1 
Investments related to long-term incentive plans237.1   29.2 266.3 
Other equity and debt investments17.5 14.0 1.6 38.4 71.5 
Total Assets Measured at Fair Value$512.2 $185.3 $6.3 $103.1 $806.9 
Liabilities
Securities sold short$244.9 $ $ $ $244.9 
Contingent consideration liabilities  27.5  27.5 
Total Liabilities Measured at Fair Value$244.9 $ $27.5 $ $272.4 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of September 30, 2024
Assets
Investments, at fair value
Sponsored funds and separate accounts$306.3 $157.4 $5.2 $40.2 $509.1 
Investments related to long-term incentive plans242.5   29.1 271.6 
Other equity and debt investments4.1 11.1 2.6 39.5 57.3 
Total Assets Measured at Fair Value$552.9 $168.5 $7.8 $108.8 $838.0 
Liabilities
Securities sold short$178.1 $ $ $ $178.1 
Contingent consideration liabilities  28.2  28.2 
Total Liabilities Measured at Fair Value$178.1 $ $28.2 $ $206.3 
11

Investments for which fair value was estimated using reported NAV as a practical expedient primarily consist of nonredeemable private equity, debt and infrastructure funds, and redeemable alternative credit, global equity, private real estate funds and alternatives. These investments were as follows:
(in millions)December 31,
2024
September 30,
2024
Nonredeemable investments1
Investments with known liquidation periods$29.7 $32.4 
Investments with unknown liquidation periods15.7 16.1 
Redeemable investments2
57.7 60.3 
Unfunded commitments15.6 14.0 
_______________
1The investments are expected to be returned through distributions over the life of the funds as a result of liquidations of the funds’ underlying assets. Investments with known liquidation periods have an expected weighted-average life of 1.9 years at December 31, 2024 and September 30, 2024.
2Investments are redeemable on a semi-monthly, monthly and quarterly basis.
Financial instruments that were not measured at fair value were as follows:
(in millions)Fair Value
Level
December 31, 2024September 30, 2024
Carrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
Financial Assets
Cash and cash equivalents1$2,808.0 $2,808.0 $3,309.5 $3,309.5 
Other investments
Time deposits28.7 8.7 9.8 9.8 
Equity securities3401.4 401.4 270.9 270.9 
Financial Liability
Debt2$2,775.8 $2,315.0 $2,780.3 $2,387.0 
12

Note 7 Consolidated Investment Products
CIPs consist of mutual and other investment funds, limited partnerships and similar structures and CLOs, all of which are sponsored by the Company, and include both voting interest entities and variable interest entities (“VIEs”). The Company had 75 CIPs, including 22 CLOs, as of December 31, 2024 and 77 CIPs, including 22 CLOs, as of September 30, 2024.
The balances related to CIPs included in the Company’s consolidated balance sheets were as follows:
(in millions)December 31,
2024
September 30,
2024
Assets
Cash and cash equivalents$837.1 $1,099.4 
Receivables141.5 217.5 
Investments, at fair value11,897.4 11,034.9 
Total Assets$12,876.0 $12,351.8 
Liabilities
Accounts payable and accrued expenses$861.2 $861.3 
Debt9,055.3 9,341.5 
Other liabilities11.2 39.9 
Total liabilities9,927.7 10,242.7 
Redeemable Noncontrolling Interests1,466.5 687.8 
Stockholders Equity
Franklin Resources, Inc.’s interests1,098.0 1,080.9 
Nonredeemable noncontrolling interests383.8 340.4 
Total stockholders’ equity1,481.8 1,421.3 
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders Equity
$12,876.0 $12,351.8 
The CIPs did not have a significant impact on net income attributable to the Company during the three months ended December 31, 2024 and 2023.
The Company has no right to the CIPs’ assets, other than its direct equity investments in them and investment management and other fees earned from them. The debt holders of the CIPs have no recourse to the Company’s assets beyond the level of its direct investment; therefore the Company bears no other risks associated with the CIPs’ liabilities.
Fair Value Measurements
Assets of CIPs measured at fair value on a recurring basis were as follows: 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of December 31, 2024
Assets
Cash and cash equivalents of CLOs$519.3 $ $ $ $519.3 
Receivables of CLOs 80.8   80.8 
Investments
Equity and debt securities485.5 1,501.9 573.5 124.0 2,684.9 
Loans 9,212.3 0.2  9,212.5 
Total Assets Measured at Fair Value$1,004.8 $10,795.0 $573.7 $124.0 $12,497.5 
13

(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of September 30, 2024
Assets
Cash and cash equivalents of CLOs$764.3 $ $ $ $764.3 
Receivables of CLOs 149.6   149.6 
Investments
Equity and debt securities229.7 889.4 550.1 187.1 1,856.3 
Loans 9,178.1 0.5  9,178.6 
Total Assets Measured at Fair Value$994.0 $10,217.1 $550.6 $187.1 $11,948.8 
Investments for which fair value was estimated using reported NAV as a practical expedient consist of a redeemable U.S. equity fund, a redeemable global hedge fund and nonredeemable private debt funds. These investments were as follows:
(in millions)December 31,
2024
September 30,
2024
Nonredeemable investments1
Investments with unknown liquidation periods$53.8 $49.0 
Redeemable investments2
70.2 138.1 
Unfunded commitments3
42.8 42.8 
_______________
1The investments are expected to be returned through distributions over the life of the funds as a result of liquidations of the funds’ underlying assets.
2Investments are redeemable on a monthly basis and liquidation periods are unknown.
3Of the total unfunded commitments, the Company was contractually obligated to fund $9.9 million based on its ownership percentage in the CIPs, at December 31, 2024 and September 30, 2024.

Changes in Level 3 assets were as follows: 
(in millions)Equity and Debt
Securities
for the three months ended December 31, 2024
Balance at October 1, 2024$550.1 
Gains included in investment and other income (losses) of consolidated investment products, net22.0 
Purchases9.2 
Sales
(11.6)
Net consolidations3.8 
Balance at December 31, 2024$573.5 
Change in unrealized gains included in net income relating to assets held at December 31, 2024$22.3 

14

(in millions)Equity and Debt
Securities
LoansTotal 
Level 3
Assets
for the three months ended December 31, 2023
Balance at October 1, 2023$584.9 $ $584.9 
Losses included in investment and other income (losses) of consolidated investment products, net(38.1) (38.1)
Purchases3.8  3.8 
Sales
(0.2) (0.2)
Transfers into Level 31.1 0.6 1.7 
Balance at December 31, 2023$551.5 $0.6 $552.1 
Change in unrealized losses included in net income relating to assets held at December 31, 2023$(37.8)$ $(37.8)
Valuation techniques and significant unobservable inputs used in Level 3 fair value measurements were as follows:
(in millions)
as of December 31, 2024Fair ValueValuation TechniqueSignificant Unobservable Inputs
Range (Weighted Average1)
Equity and debt securities$302.2 Market comparable companiesEnterprise value/ Revenue multiple
1.428.7 (11.0)
Discount for lack of marketability
5.8%–11.8% (8.0%)
219.1 Market pricingPrivate sale pricing
$0.01–$1,120.00 ($82.93) per share
Discount for lack of marketability
9.7%–13.3% (10.4%)
52.2 Discounted cash flowDiscount rate
6.3%–6.4% (6.3%)
(in millions)
as of September 30, 2024Fair ValueValuation TechniqueSignificant Unobservable Inputs
Range (Weighted Average1)
Equity and debt securities$291.6 Market comparable companiesEnterprise value/ Revenue multiple
1.222.8 (10.9)
Discount for lack of marketability
0.1%–10.4% (8.1%)
214.5 Market pricingPrivate sale pricing
$0.01–$1,000.00 ($73.04) per share
Discount for lack of marketability
9.8%–17.5% (11.5%)
44.0 Discounted cash flowDiscount rate6.8%
__________________
1Based on the relative fair value of the instruments.

If the relevant significant inputs used in the market-based valuations, other than discount for lack of marketability, were independently higher (lower) as of December 31, 2024, the resulting fair value of the assets would be higher (lower). If the relevant significant inputs used in the discounted cash flow, as well as the discount for lack of marketability used in the market-based valuations, were independently higher (lower) as of December 31, 2024, the resulting fair value of the assets would be lower (higher).
15

Financial instruments of CIPs that were not measured at fair value were as follows:
(in millions)Fair Value
Level
December 31, 2024September 30, 2024
Carrying
Value
Estimated
Fair Value
Carrying
Value
Estimated
Fair Value
Financial Asset
Cash and cash equivalents1$317.8 $317.8 $335.1 $335.1 
Financial Liabilities
Debt of CLOs1
2 or 3$9,055.3 $8,858.1 $9,341.5 $9,167.3 
__________________
1Substantially all was Level 2.
Debt
Debt of CLOs totaled $9,055.3 million and $9,341.5 million at December 31, 2024 and September 30, 2024. The debt had fixed and floating interest rates ranging from 2.39% to 13.68% with a weighted-average effective interest rate of 7.30% at December 31, 2024, and from 2.39% to 13.73% with a weighted-average effective interest rate of 7.36% at September 30, 2024. The floating rates were based on the Secured Overnight Financing Rate.
The contractual maturities for the debt of CLOs at December 31, 2024 were as follows:
(in millions)
for the fiscal years ending September 30,Amount
2025 (remainder of year)$120.1 
2026 
2027 
2028 
2029 
Thereafter8,935.2 
Total$9,055.3 
Collateralized Loan Obligations
The unpaid principal balance and fair value of the investments of CLOs were as follows:
(in millions)December 31,
2024
September 30,
2024
Unpaid principal balance$9,420.8 $9,371.9 
Difference between unpaid principal balance and fair value(24.1)(19.8)
Fair Value$9,396.7 $9,352.1 
Investments 90 days or more past due were immaterial at December 31, 2024 and September 30, 2024.
The Company recognized $11.7 million and $20.8 million of net gains during the three months ended December 31, 2024 and 2023, related to its own economic interests in the CLOs. The aggregate principal amount due of the debt of CLOs was $9,015.0 million and $9,282.8 million at December 31, 2024 and September 30, 2024.
16

Note 8 Redeemable Noncontrolling Interests
Changes in redeemable noncontrolling interests were as follows:
(in millions)20242023
CIPsMinority InterestsTotalCIPsMinority InterestsTotal
for the three months ended December 31,
Balance at beginning of period$687.8 $634.0 $1,321.8 $580.1 $446.0 $1,026.1 
Net income (loss)38.9 10.7 49.6 (2.9)12.4 9.5 
Net subscriptions (distributions) and other175.6 (3.7)171.9 38.1 (1.1)37.0 
Net consolidations (deconsolidations)564.2  564.2 (60.0) (60.0)
Adjustment to fair value (1.5)(1.5) 65.9 65.9 
Balance at End of Period$1,466.5 $639.5 $2,106.0 $555.3 $523.2 $1,078.5 
Note 9 Nonconsolidated Variable Interest Entities
VIEs for which the Company is not the primary beneficiary consist of sponsored funds and other investment products in which the Company has an equity ownership interest. The Company’s maximum exposure to loss from these VIEs consists of equity investments, investment management and other fee receivables as follows: 
(in millions)December 31,
2024
September 30,
2024
Investments$1,106.8 $1,074.4 
Receivables219.8 226.0 
Total$1,326.6 $1,300.4 
While the Company has no legal or contractual obligation to do so, it routinely makes cash investments in the course of launching sponsored funds. As it has done in the past, the Company also may voluntarily elect to provide its sponsored funds with additional direct or indirect financial support based on its business objectives. The Company did not provide financial or other support to its sponsored funds assessed as VIEs during the three months ended December 31, 2024 or fiscal year 2024.
Note 10 Commitments and Contingencies
Legal Proceedings
India Credit Fund Closure Matters. During the three months ended December 31, 2024, there were no significant changes from the disclosure in the Form 10‑K for the fiscal year ended September 30, 2024.
Western Asset Management Investigations. As previously disclosed, the Company launched an internal investigation into certain trade allocations of treasury derivatives in select Western Asset Management (“WAM”) managed accounts. WAM received notification of parallel investigations by the SEC and the U.S. Department of Justice (“DOJ”). WAM also received notice of an investigation into these trading activities by the CFTC. As previously disclosed, Ken Leech, the former co-Chief Investment Officer of WAM, received a “Wells Notice” from the staff of the SEC in August 2024 and is now on administrative leave. On November 25, 2024, the SEC filed a complaint in the United States District Court for the Southern District of New York against Mr. Leech alleging violations of certain laws related to trade allocations. Concurrently, the DOJ filed an indictment with the United States District Court for the Southern District of New York against Mr. Leech for similar allegations and for false statements made to the SEC. The Company and WAM have fully cooperated, and will continue to fully cooperate with these investigations.
17

Blockchain Litigation. The Company, two of its subsidiaries, the Company’s CEO, and an individual employee (collectively the “Defendants”) are named as defendants in litigation pending in the United States District Court for the Northern District of California. The action was filed in November 2021 by Blockchain Innovation, LLC (the “Plaintiff”) and relates to a startup entity in which the Company subsidiary Defendant previously owned all voting shares. The Plaintiff asserts it acquired the assets of the startup entity and claims that the Defendants improperly wound down the startup and misappropriated its intellectual property. The action asserts claims for alleged breaches of fiduciary duties, aiding and abetting breaches of fiduciary duty, breach of contract, and misappropriation of trade secrets. The Plaintiff is seeking various forms of relief, including, among other things, compensatory damages, punitive and exemplary damages, and an injunction including to prevent the Defendants from using any allegedly misappropriated trade secrets and technology. The trial is scheduled to begin in March 2025.
The Defendants believe the claims are without merit and are vigorously defending against the action. The Company cannot predict the outcome of this lawsuit and is unable to estimate any reasonably possible loss or range of loss (including with respect to indemnification of the individual Defendants) that may potentially result if the Plaintiff were to prevail on any of its claims.
Other Litigation and Regulatory Matters. The Company is from time to time involved in other litigation relating to claims arising in the normal course of business. Management is of the opinion that the ultimate resolution of such claims will not materially affect the Company’s business, financial position, results of operations or liquidity. In management’s opinion, an adequate accrual has been made as of December 31, 2024 to provide for any probable losses that may arise from such matters for which the Company could reasonably estimate an amount.
Indemnifications and Guarantees
In the ordinary course of business or in connection with certain acquisition agreements, the Company enters into contracts that provide for indemnifications by the Company in certain circumstances. In addition, certain Company entities guarantee certain financial and performance-related obligations of various Franklin subsidiaries. The Company is also subject to certain legal requirements and agreements providing for indemnifications of directors, officers and personnel against liabilities and expenses they may incur under certain circumstances in connection with their service. The terms of these indemnities and guarantees vary pursuant to applicable facts and circumstances, and from agreement to agreement. Future payments for claims against the Company under these indemnities or guarantees could negatively impact the Company’s financial condition. In management’s opinion, no material loss was deemed probable or reasonably possible pursuant to such indemnification agreements and/or guarantees as of December 31, 2024.
Other Commitments and Contingencies
At December 31, 2024, there were no other material changes in the other commitments and contingencies as reported in the Company’s Annual Report on Form 10-K for fiscal year 2024.
Note 11 Stock-Based Compensation
Stock and stock unit award activity was as follows:
(shares in thousands)Time-Based
Shares
Performance-
Based Shares
Total
Shares
Weighted-
Average
Grant-Date
Fair Value
for the three months ended December 31, 2024
Nonvested balance at October 1, 202416,594 3,314 19,908 $24.03 
Granted7,812 169 7,981 20.73 
Vested(524)(166)(690)26.34 
Forfeited/canceled(226)(72)(298)24.95 
Nonvested Balance at December 31, 202423,656 3,245 26,901 $22.98 
Total unrecognized compensation expense related to nonvested stock and stock unit awards was $310.4 million at December 31, 2024. This expense is expected to be recognized over a remaining weighted-average vesting period of 2.1 years.
18

Note 12 Investment and Other Income, Net
Investment and other income, net consisted of the following:
 
Three Months Ended
December 31,
(in millions)20242023
Dividend and interest income$43.1 $54.8 
Gains (losses) on investments, net(57.1)60.1 
Income (losses) from investments in equity method investees(7.6)56.9 
Gains (losses) on derivatives, net6.6 (8.2)
Rental income11.2 10.8 
Foreign currency exchange gains (losses), net14.5 (7.4)
Other, net(0.2)6.2 
Investment and other income, net$10.5 $173.2 
Net gains (losses) recognized on equity securities measured at fair value and trading debt securities that were held by the Company were $(87.2) million for the three months ended December 31, 2024 and $68.5 million for the three months ended December 31, 2023.
19

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
FORWARD-LOOKING STATEMENTS
This Form 10-Q and the documents incorporated by reference herein may include forward-looking statements that reflect our current views with respect to future events, financial performance and market conditions. Such statements are provided under the “safe harbor” protection of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and generally can be identified by words or phrases written in the future tense and/or preceded by words such as “anticipate,” “believe,” “could,” “depends,” “estimate,” “expect,” “intend,” “likely,” “may,” “plan,” “potential,” “seek,” “should,” “will,” “would,” or other similar words or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements.
Forward-looking statements involve a number of known and unknown risks, uncertainties and other important factors that may cause actual results and outcomes to differ materially from any future results or outcomes expressed or implied by such forward-looking statements, including market and volatility risks, investment performance and reputational risks, global operational risks, competition and distribution risks, third-party risks, technology and security risks, human capital risks, cash management risks, and legal and regulatory risks. The forward-looking statements contained in this Form 10-Q or that are incorporated by reference herein are qualified in their entirety by reference to the risks and uncertainties disclosed in this Form 10-Q and/or discussed under the headings “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024 (“fiscal year 2024”).
While forward-looking statements are our best prediction at the time that they are made, you should not rely on them and are cautioned against doing so. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other possible future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. They are neither statements of historical fact nor guarantees or assurances of future performance. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them.
The initiation or unfavorable resolution of legal proceedings or other claims and regulatory and other governmental investigations or inquiries, including the Western Asset Management (“WAM”) investigations described under the heading “Risk Factors” and in “Note 16 - Commitments and Contingencies” to our audited financial statements contained in our Annual Report on Form 10-K for fiscal year 2024, and in “Note 10 - Commitments and Contingencies” to our unaudited interim financial statements contained in this Form 10-Q, may result in additional costs, monetary judgments, settlements or other remedies, including fines, penalties, restitution and/or alterations in our business practices or those of our specialist investment managers. In addition, these matters may cause reputational harm to us or our specialist investment managers and could result in additional expenses and collateral costs, outflows of assets under management or other financial impacts that could materially affect our results of operations and the price of our common stock.
If a circumstance occurs after the date of this Form 10-Q that causes any of our forward-looking statements to be inaccurate, whether as a result of new information, future developments or otherwise, we undertake no obligation to announce publicly the change to our expectations, or to make any revision to our forward-looking statements, to reflect any change in assumptions, beliefs or expectations, or any change in events, conditions or circumstances upon which any forward-looking statement is based, unless required by law.
In this section, we discuss and analyze the results of operations and financial condition of Franklin Resources, Inc. (“Franklin”) and its subsidiaries (collectively, the “Company”). The following discussion should be read in conjunction with our Annual Report on Form 10-K for fiscal year 2024 filed with the U.S. Securities and Exchange Commission (the “SEC”), and the consolidated financial statements and notes thereto included elsewhere in this Form 10-Q. Words such as “we,” “us,” “our” and similar terms refer to the Company.
20

OVERVIEW
Franklin is a holding company with subsidiaries operating under our Franklin Templeton® and/or subsidiary brand names. We are a global investment management organization that derives operating revenues and net income from providing investment management and related services to investors in jurisdictions worldwide. We deliver our investment capabilities through a variety of investment products, which include our sponsored funds, as well as institutional and high-net-worth separate accounts, retail separately managed account programs, sub-advised products and other investment vehicles. Related services include fund administration, sales and distribution, and shareholder servicing. We may perform services directly or through third parties. We offer our services and products under our various distinct brand names, including, but not limited to, Franklin®, Templeton®, Legg Mason®, Alcentra®, Benefit Street Partners®, Brandywine Global Investment Management®, Canvas®, Clarion Partners®, ClearBridge Investments®, Fiduciary Trust International™, Franklin Mutual Series®, K2®, Lexington Partners®, Martin Currie®, O’Shaughnessy®, Putnam®, Royce® and Western Asset Management Company®. We offer a broad product mix of equity, fixed income, alternative, multi-asset and cash management asset classes and solutions that meet a wide variety of specific investment goals and needs for individual and institutional investors. We also provide sub-advisory services to certain investment products sponsored by other companies which may be sold to investors under the brand names of those other companies or on a co-branded basis.
The level of our revenues depends largely on the level and relative mix of assets under management (“AUM”). As noted in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year 2024, the amount and mix of our AUM are subject to significant fluctuations, including as a result of reputational harm, that can negatively impact our revenues and income. The level of our revenues also depends on the fees charged for our services, which are based on contracts with our funds and customers, fund sales, and the number of shareholder transactions and accounts. These arrangements could change in the future.
During our first fiscal quarter, global equity markets provided mixed results. U.S. equity markets provided positive returns, supported by the result of the presidential election and expectations of policies to improve economic growth and reduce taxes and regulation, while most international markets declined amid fears of economic contraction, increasing inflation and political instability. The S&P 500 Index increased 2.4%, while the MSCI World Index decreased by 0.1% for the quarter. The Bloomberg Global Aggregate Index decreased 5.1% during the quarter, reflecting geopolitical tensions and fluctuating inflation rates.
Our total AUM at December 31, 2024 was $1,575.7 billion, 6% lower than at September 30, 2024 and 8% higher than at December 31, 2023. Monthly average AUM (“average AUM”) for the three months ended December 31, 2024 increased 17% from the same period in the prior fiscal year.
The business and regulatory environments in which we operate globally remain complex, uncertain and subject to change. We are subject to various laws, rules and regulations globally that impose restrictions, limitations, registration, reporting and disclosure requirements on our business, and add complexity to our global compliance operations.
Uncertainties regarding the global economy remain for the foreseeable future. As we continue to confront the challenges of the current economic and regulatory environments, we remain focused on the investment performance of our products and on providing high quality service to our clients. We continuously perform reviews of our business model. While we remain focused on expense management, we will also seek to attract, retain and develop personnel and invest strategically in systems and technology that will provide a secure and stable environment. We will continue to seek to protect and further our brand recognition while developing and maintaining broker-dealer and client relationships. The success of these and other strategies may be influenced by the factors discussed in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year 2024.    
21

RESULTS OF OPERATIONS
Three Months Ended
December 31,
Percent
Change
(in millions, except per share data)20242023
Operating revenues$2,251.6$1,991.113 %
Operating income219.0206.5%
Operating margin1
9.7 %10.4 %
Net income attributable to Franklin Resources, Inc.$163.6$251.3(35 %)
Diluted earnings per share0.290.50(42 %)
As adjusted (non-GAAP):2
Adjusted operating income$412.8$417.0(1 %)
Adjusted operating margin24.5 %27.3 %
Adjusted net income$320.5$328.5(2 %)
Adjusted diluted earnings per share0.590.65(9 %)
_________________
1Defined as operating income divided by operating revenues.
2“Adjusted operating income,” “adjusted operating margin,” “adjusted net income” and “adjusted diluted earnings per share” are based on methodologies other than generally accepted accounting principles. See “Supplemental Non-GAAP Financial Measures” for definitions and reconciliations of these measures.
ASSETS UNDER MANAGEMENT
AUM by asset class was as follows:
(in billions)December 31,
2024
December 31,
2023
Percent
Change
Equity
$620.0 $467.5 33 %
Fixed Income469.5 511.7 (8 %)
Alternative 248.8 256.2 (3 %)
Multi-Asset174.0 154.6 13 %
Cash Management63.4 65.5 (3 %)
Total$1,575.7 $1,455.5 8 %
Average AUM and the mix of average AUM by asset class are shown below.
(in billions)
Average AUM 1
Percent
Change
Mix of Average AUM
for the three months ended December 31,2024202320242023
Equity
$629.1 $439.2 43 %38 %32 %
Fixed Income516.8 489.7 %32 %35 %
Alternative248.8 255.6 (3 %)15 %18 %
Multi-Asset175.6 147.3 19 %11 %11 %
Cash Management64.2 62.4 %%%
Total$1,634.5 $1,394.2 17 %100 %100 %
_______________
1Average AUM is calculated as the average of the month-end AUM for the trailing four months.
22

Components of the change in AUM are shown below. Net market change, distributions and other includes appreciation (depreciation), distributions to investors that represent return on investments and return of capital, and foreign exchange revaluation.
(in billions)
Three Months Ended
December 31,
Percent
Change
20242023
Beginning AUM$1,678.6 $1,374.2 22 %
Long-term inflows97.8 68.9 42 %
Long-term outflows(147.8)(73.9)100 %
Long-term net flows(50.0)(5.0)900%
Cash management net flows— 4.7 (100 %)
Total net flows(50.0)(0.3)NM
Net market change, distributions and other(52.9)81.6 NM
Ending AUM$1,575.7 $1,455.5 8 %
Components of the change in AUM by asset class were as follows:
(in billions)
Equity
Fixed IncomeAlternativeMulti-AssetCash
Management
Total
for the three months ended
December 31, 2024
AUM at October 1, 2024$632.1 $556.4 $249.9 $176.2 $64.0 $1,678.6 
Long-term inflows55.9 26.4 4.3 11.2 — 97.8 
Long-term outflows(43.4)(93.1)(3.5)(7.8)— (147.8)
Long-term net flows12.5 (66.7)0.8 3.4 — (50.0)
Cash management net flows— — — — — — 
Total net flows12.5 (66.7)0.8 3.4 — (50.0)
Net market change, distributions and other
(24.6)(20.2)(1.9)(5.6)(0.6)(52.9)
AUM at December 31, 2024$620.0 $469.5 $248.8 $174.0 $63.4 $1,575.7 

AUM decreased $102.9 billion, or 6%, during the three months ended December 31, 2024 due to the negative impact of $52.9 billion of net market change, distributions and other and $50.0 billion of long-term net outflows, inclusive of $67.9 billion of long-term net outflows at WAM and $20.1 billion of long-term reinvested distributions. Net market change, distributions and other primarily consists of $30.1 billion of distributions, primarily from the equity asset class, a $14.3 billion decrease from foreign exchange revaluation and $8.5 billion of market depreciation. The market depreciation occurred primarily in the fixed income and multi-asset classes. Foreign exchange revaluation from AUM in products that are not U.S. dollar denominated was primarily due to a stronger U.S. dollar compared to the Euro, Australian dollar, Japanese Yen and Canadian dollar.

Long-term inflows increased 42% to $97.8 billion, as compared to the prior year period, driven by higher inflows in equity and multi-asset open end funds, equity sub-advised mutual funds, and equity retail separately managed accounts. Long-term outflows increased 100% to $147.8 billion, substantially due to higher outflows across multiple fixed income vehicles at WAM, and to a lesser extent, higher outflows from equity open end funds and retail separately managed accounts. WAM outflows have increased significantly following the investment performance issues and the announcement of ongoing regulatory investigations.
23

(in billions)
Equity
Fixed IncomeAlternativeMulti-AssetCash
Management
Total
for the three months ended
December 31, 2023
AUM at October 1, 2023$430.4 $483.1 $254.9 $145.0 $60.8 $1,374.2 
Long-term inflows27.0 28.3 5.9 7.7 — 68.9 
Long-term outflows(26.8)(36.7)(3.2)(7.2)— (73.9)
Long-term net flows0.2 (8.4)2.7 0.5 — (5.0)
Cash management net flows— — — — 4.7 4.7 
Total net flows0.2 (8.4)2.7 0.5 4.7 (0.3)
Net market change, distributions and other
36.9 37.0 (1.4)9.1 — 81.6 
AUM at December 31, 2023$467.5 $511.7 $256.2 $154.6 $65.5 $1,455.5 
AUM by sales region was as follows:
(in billions)December 31,
2024
December 31,
2023
Percent
Change
United States$1,102.5 $1,019.4 %
International
Europe, Middle East and Africa
193.7 180.6 %
Asia-Pacific165.2 150.5 10 %
Americas, excl. U.S.114.3 105.0 %
Total international473.2 436.1 %
Total$1,575.7 $1,455.5 8 %
Investment Performance Overview
A key driver of our overall success is the long-term investment performance of our investment products. A measure of the performance of these products is the percentage of AUM exceeding peer group medians and benchmarks. We compare the relative performance of our mutual funds against peers, and of our strategy composites against benchmarks.
The performance of our mutual fund products against peer group medians and of our strategy composites against benchmarks is presented in the table below.
Peer Group Comparison1
Benchmark Comparison2
% of Mutual Fund AUM
 in Top Two Peer Group Quartiles
% of Strategy Composite AUM
 Exceeding Benchmark
as of December 31, 20241-Year3-Year5-Year10-Year1-Year3-Year5-Year10-Year
Equity53 %60 %46 %60 %35 %43 %41 %46 %
Fixed Income67 %65 %63 %58 %51 %57 %68 %86 %
Total AUM3
50 %67 %46 %53 %45 %51 %53 %63 %
__________________
1Mutual fund performance is sourced from Morningstar and measures the percent of ranked AUM in the top two quartiles versus peers. Total mutual fund AUM measured for the 1-, 3-, 5- and 10-year periods represents 38%, 38%, 38% and 36% of our total AUM as of December 31, 2024.
2Strategy composite performance measures the percent of composite AUM beating its benchmark. The benchmark comparisons are based on each account’s/composite’s (strategy composites may include retail separately managed accounts and mutual fund assets managed as part of the same strategy) return as compared to a market index that has been selected to be generally consistent with the asset class of the account/composite. Total strategy composite AUM measured for the 1-, 3-, 5- and 10-year periods represents 54%, 54%, 54% and 48% of our total AUM as of December 31, 2024.
3Total mutual fund AUM includes performance of our alternative and multi-asset funds, and total strategy composite AUM includes performance of our alternative composites. Alternative and multi-asset AUM represent 16% and 11% of our total AUM at December 31, 2024.
Mutual fund performance data includes U.S. and cross-border domiciled mutual funds and exchange-traded funds, excludes cash management and fund of funds, and assumes the reinvestment of dividends.
24

Past performance is not indicative of future results. For strategy composite AUM included in institutional and retail separately managed accounts and investment funds managed in the same strategy as separate accounts, performance comparisons are based on gross-of-fee performance. For investment funds which are not managed in a separate account format, performance comparisons are based on net-of-fee performance. These performance comparisons do not reflect the actual performance of any specific separate account or investment fund; individual separate account and investment fund performance may differ. The information in this presentation is provided solely for use in connection with this document, and is not directed toward existing or potential clients of Franklin.
OPERATING REVENUES
The table below presents the percentage change in each operating revenue category.
(in millions)
Three Months Ended
December 31,
Percent
Change
20242023
Investment management fees$1,799.3 $1,652.2 %
Sales and distribution fees375.5 296.4 27 %
Shareholder servicing fees63.5 32.5 95 %
Other13.3 10.0 33 %
Total Operating Revenues$2,251.6 $1,991.1 13 %
Investment Management Fees
Investment management fees increased $147.1 million for the three months ended December 31, 2024 primarily due to a 17% increase in average AUM, partially offset by a decrease in performance fees and catch-up fees recognized in the prior year at the closing of fundraising rounds in a secondary private equity fund, which ended in January 2024. The increases in average AUM primarily occurred in the equity and multi-asset asset classes, driven by the acquisition of Putnam on January 1, 2024 and net market appreciation, partially offset by a decrease in the alternative asset class.
Our effective investment management fee rate excluding performance fees (annualized investment management fees excluding performance fees divided by average AUM) decreased to 40.2 basis points for the three months ended December 31, 2024, from 42.4 basis points for the same period in the prior fiscal year. The rate decrease was primarily due to increased AUM in lower fee products, including those from the acquisition of Putnam, and catch-up fees recognized in the prior year at the closing of fundraising rounds in a secondary private equity fund.
Performance fees were $141.6 million and $166.4 million for the three months ended December 31, 2024 and 2023. The decrease was primarily due to lower performance fees earned by certain of our alternative specialist investment managers, and a decrease of $3.5 million in performance fees which were passed through as compensation expense per the terms of acquisition agreements.
Sales and Distribution Fees
Sales and distribution fees by revenue driver are presented below.
(in millions)
Three Months Ended
December 31,
Percent
Change
20242023
Asset-based fees$309.1 $246.0 26 %
Sales-based fees66.4 50.4 32 %
Sales and Distribution Fees$375.5 $296.4 27 %

Asset-based distribution fees increased $63.1 million for the three months ended December 31, 2024 primarily due to revenue earned from Putnam products subsequent to the acquisition and an increase of 10% in the related average AUM, excluding the impact of the Putnam products.
Sales-based fees increased $16.0 million for the three months ended December 31, 2024 primarily due to an increase of 25% in commissionable sales and sales-based revenue earned from Putnam products subsequent to the acquisition.
25

Shareholder Servicing Fees
Shareholder servicing fees increased $31.0 million for the three months ended December 31, 2024 primarily due to fees earned by Putnam subsequent to the acquisition.
OPERATING EXPENSES
The table below presents the percentage change in each operating expense category.
 
Three Months Ended
December 31,
Percent
Change
(in millions)20242023
Compensation and benefits$991.4 $968.3 %
Sales, distribution and marketing512.3 400.8 28 %
Information systems and technology156.0 131.0 19 %
Occupancy75.1 66.7 13 %
Amortization of intangible assets112.6 85.8 31 %
General, administrative and other185.2 132.0 40 %
Total Operating Expenses$2,032.6 $1,784.6 14 %
The Putnam acquisition had a significant impact on operating expenses in the three months ended December 31, 2024, however, due to the ongoing integration of the combined businesses, it is not practicable to separately quantify the impact of the legacy Putnam business.
Compensation and Benefits
The components of compensation and benefits expenses are presented below.
Three Months Ended
December 31,
Percent
Change
(in millions)20242023
Salaries, wages and benefits$423.6 $370.9 14 %
Incentive compensation439.4 418.3 %
Acquisition-related retention1
45.8 69.1 (34 %)
Acquisition-related performance fee pass through1
69.1 72.6 (5 %)
Other1,2
13.5 37.4 (64 %)
Compensation and Benefits Expenses$991.4 $968.3 2 %
_______________
1See “Supplemental Non-GAAP Financial Measures” for additional information.
2Includes impact of gains and losses on investments related to deferred compensation plans, which is offset in investment and other income (losses), net; minority interests in certain subsidiaries, which is offset in net income (loss) attributable to redeemable noncontrolling interests; and special termination benefits.
Salaries, wages and benefits increased $52.7 million for the three months ended December 31, 2024, primarily due to higher headcount as a result of the acquisition of Putnam and annual salary increases, partially offset by the impact of headcount reductions.
Incentive compensation increased $21.1 million for the three months ended December 31, 2024, primarily due to the acquisition of Putnam and an increase in expense for deferred compensation awards, due in part to higher annual acceleration of expense related to retirement-eligible employees, partially offset by lower incentive compensation at certain specialist investment managers.
Acquisition-related retention expenses decreased $23.3 million for the three months ended December 31, 2024, primarily due to lower compensation associated with performance-based and time-based awards, partially offset by an increase due to the acquisition of Putnam.
26

Acquisition-related performance fee pass through expenses decreased $3.5 million for the three months ended December 31, 2024, due to lower pass through performance fees.
Other compensation and benefits decreased $23.9 million for the three months ended December 31, 2024, primarily due to lower net market gains on investments related to our deferred compensation plans and a decrease in special termination benefits. Special termination benefits decreased $6.3 million for the three months ended December 31, 2024 primarily due to the costs associated with workforce optimization initiatives in the prior year.
At December 31, 2024, our global workforce increased to approximately 10,100 employees from approximately 9,100 at December 31, 2023, primarily due to the acquisition of Putnam.
Sales, Distribution and Marketing
Sales, distribution and marketing expenses by cost driver are presented below.
 
Three Months Ended
December 31,
Percent
Change
(in millions)20242023
Asset-based expenses$428.2 $340.5 26 %
Sales-based expenses63.9 46.9 36 %
Amortization of deferred sales commissions20.2 13.4 51 %
Sales, Distribution and Marketing$512.3 $400.8 28 %
Asset-based expenses increased $87.7 million for the three months ended December 31, 2024 primarily due to expenses related to Putnam products subsequent to the acquisition, an increase of 10% in the related average AUM, excluding the impact of the Putnam products, and higher marketing support fees. Distribution expenses are generally not directly correlated with distribution fee revenues due to certain fee structures that do not provide full recovery of distribution costs.
Sales-based expenses increased $17.0 million for the three months ended December 31, 2024 primarily due to an increase of 25% in commissionable sales and sales-based expenses related to Putnam products subsequent to the acquisition.
Occupancy

Occupancy expenses increased $8.4 million for the three months ended December 31, 2024, primarily due to expenses incurred by Putnam subsequent to the acquisition and leased office space located at One Madison Avenue, associated with an initiative to consolidate our office space in New York City.
Information Systems and Technology

Information systems and technology expenses increased $25.0 million for the three months ended December 31, 2024, primarily due to expenses incurred by Putnam subsequent to the acquisition, and higher technology consulting, software, and market data costs.
Amortization of Intangible Assets

Amortization of intangible assets increased $26.8 million for the three months ended December 31, 2024, primarily due to a reduction in the remaining useful life of definite-lived intangible assets related to WAM.
General, Administrative and Other

General, administrative and other operating expenses increased $53.2 million for the three months ended December 31, 2024, primarily due to the acquisition of Putnam, an increase of $18.5 million in legal and other professional fees, net of a $10.0 million insurance recovery, an increase of $3.7 million in advertising expenses and an increase of $2.4 million in travel and entertainment due to higher activity levels.
27

OTHER INCOME (EXPENSES)
Other income (expenses) consisted of the following:
Three Months Ended
December 31,
Percent
Change
(in millions)20242023
Investment and other income, net:
Dividend and interest income
$43.1 $54.8 (21 %)
Gains (losses) on investments, net(57.1)60.1 NM
Income (losses) from investments in equity method investees(7.6)56.9 NM
Gains (losses) on derivatives, net6.6 (8.2)NM
Rental income
11.2 10.8 %
Foreign currency exchange gains (losses), net14.5 (7.4)NM
Other, net
(0.2)6.2 NM
Investment and other income, net10.5 173.2 (94 %)
Interest expense(23.1)(18.8)23 %
Investment and other income (losses) of consolidated investment products, net114.1 (23.8)NM
Expenses of consolidated investment products(7.3)(5.9)24 %
Other Income, Net$94.2 $124.7 (24 %)
Dividend and interest income decreased $11.7 million for the three months ended December 31, 2024, primarily due to lower average balances and lower yields.
Investments held by the Company generated net losses of $57.1 million in the three months ended December 31, 2024, as compared to net gains of $60.1 million for the three months ended December 31, 2023. The net losses in the current year and net gains in the prior year were primarily from investments in nonconsolidated funds and separate accounts and assets invested for deferred compensation plans.
Equity method investees generated losses of $7.6 million for the three months ended December 31, 2024, as compared to income of $56.9 million in the prior year, largely related to various global alternative and equity funds.
Net foreign currency exchange gains were $14.5 million for the three months ended December 31, 2024, as compared to net losses of $7.4 million for the three months ended December 31, 2023. The U.S. dollar strengthened in the current year against the Euro and British Pound, which resulted in foreign exchange gains on cash and cash equivalents denominated in U.S. dollars held by our European subsidiaries, as compared to weakening against the same currencies, which resulted in foreign exchange losses, in the prior year.
Interest expense increased $4.3 million for the three months ended December 31, 2024 primarily due to an increase in interest recognized on tax reserves, partially offset by lower accretion on Lexington deferred purchase consideration and interest recognized in the prior year on the $250 million senior notes which were repaid in July 2024.
Investments held by consolidated investment products (“CIPs”) generated investment gains and other income of $114.1 million in the three months ended December 31, 2024, largely related to gains on holdings of various alternative, equity, fixed income, and multi-asset funds. Investments held by CIPs generated losses of $23.8 million in the three months ended December 31, 2023, largely related to losses on holdings of various alternative and equity funds.
Expenses of CIPs increased $1.4 million for the three months ended December 31, 2024, due to activity of the funds.
28

Our cash, cash equivalents and investments portfolio by asset class and accounting classification at December 31, 2024, excluding third-party assets of CIPs, was as follows:
Accounting Classification1
Total
(in millions)Cash and
Cash
Equivalents
Investments
at
Fair Value
Equity
Method
Investments
Other InvestmentsDirect
Investments
in CIPs
Cash and Cash Equivalents$2,808.0 $— $— $— $— $2,808.0 
Investments
Alternative— 230.4 916.2 221.4 519.7 1,887.7 
Equity— 450.8 193.6 152.5 189.5 986.4 
Fixed Income— 104.3 63.0 36.2 231.6 435.1 
Multi-Asset— 21.4 2.7 — 157.2 181.3 
Total investments— 806.9 1,175.5 410.1 1,098.0 3,490.5 
Total Cash and Cash Equivalents and Investments2, 3
$2,808.0 $806.9 $1,175.5 $410.1 $1,098.0 $6,298.5 
 
______________
1See Note 1 – Significant Accounting Policies in the notes to consolidated financial statements in Item 8 of Part II of our Annual Report on Form 10-K for fiscal year 2024 for information on investment accounting classifications.
2Total cash and cash equivalents and investments includes $4,508.2 million maintained for operational activities, including investments in sponsored funds and other products, and $434.3 million necessary to comply with regulatory requirements.
3Total cash and cash equivalents and investments includes approximately $356 million attributable to employee-owned and other third-party investments made through partnerships which are offset in noncontrolling interests, approximately $361 million of investments that are subject to long-term repurchase agreements and other net financing arrangements, and approximately $437 million of cash and investments related to deferred compensation plans.
TAXES ON INCOME

Our effective income tax rate was 25.9% and 22.6% for the three months ended December 31, 2024 and 2023. The rate increase was primarily due to tax expenses from stock-based compensation, as compared to a tax benefit in the prior year.

Our effective income tax rate reflects the relative contributions of earnings in the jurisdictions in which we operate, which have varying tax rates. Changes in our pre-tax income mix, tax rates or tax legislation in such jurisdictions may affect our effective income tax rate and net income.
SUPPLEMENTAL NON-GAAP FINANCIAL MEASURES
As supplemental information, we are providing performance measures for “adjusted operating income,” “adjusted operating margin,” “adjusted net income” and “adjusted diluted earnings per share,” each of which is based on methodologies other than generally accepted accounting principles (“non-GAAP measures”). Management believes these non-GAAP measures are useful indicators of our financial performance and may be helpful to investors in evaluating our relative performance against industry peers.
29

“Adjusted operating income,” “adjusted operating margin,” “adjusted net income” and “adjusted diluted earnings per share” are defined below, followed by reconciliations of operating income, operating margin, net income attributable to Franklin Resources, Inc. and diluted earnings per share on a U.S. GAAP basis to these non-GAAP measures. Non-GAAP measures should not be considered in isolation from, or as substitutes for, any financial information prepared in accordance with U.S. GAAP, and may not be comparable to other similarly titled measures of other companies. Additional reconciling items may be added in the future to these non-GAAP measures if deemed appropriate.
Adjusted Operating Income
We define adjusted operating income as operating income adjusted to exclude the following:
Elimination of operating revenues upon consolidation of investment products.
Acquisition-related items:
Acquisition-related retention compensation.
Other acquisition-related expenses including professional fees, technology costs and fair value adjustments related to contingent consideration assets and liabilities.
Amortization of intangible assets.
Impairment of intangible assets and goodwill, if any.
Special termination benefits and other expenses related to workforce optimization initiatives related to past acquisitions and certain initiatives undertaken by the Company.
Impact on compensation and benefits expense from gains and losses on investments related to deferred compensation plans, which is offset in investment and other income (losses), net.
Impact on compensation and benefits expense related to minority interests in certain subsidiaries, which is offset in net income (loss) attributable to redeemable noncontrolling interests.
Adjusted Operating Margin
We calculate adjusted operating margin as adjusted operating income divided by adjusted operating revenues. We define adjusted operating revenues as operating revenues adjusted to exclude the following:
Elimination of operating revenues upon consolidation of investment products.
Acquisition-related performance-based investment management fees which are passed through as compensation and benefits expense.
Sales and distribution fees and a portion of investment management fees allocated to cover sales, distribution and marketing expenses paid to the financial advisers and other intermediaries who sell our funds on our behalf.

Adjusted Net Income and Adjusted Diluted Earnings Per Share
We define adjusted net income as net income attributable to Franklin Resources, Inc. adjusted to exclude the following:
Activities of CIPs.
30

Acquisition-related items:
Acquisition-related retention compensation.
Other acquisition-related expenses including professional fees, technology costs and fair value adjustments related to contingent consideration assets and liabilities.
Amortization of intangible assets.
Impairment of intangible assets and goodwill, if any.
Interest expense for amortization of debt premium from acquisition-date fair value adjustment.
Special termination benefits and other expenses related to workforce optimization initiatives related to past acquisitions and certain initiatives undertaken by the Company.
Net gains or losses on investments related to deferred compensation plans which are not offset by compensation and benefits expense.
Net compensation and benefits expense related to minority interests in certain subsidiaries not offset by net income (loss) attributable to redeemable noncontrolling interests.
Unrealized investment gains and losses.
Net income tax expense of the above adjustments based on the respective blended rates applicable to the adjustments.
We define adjusted diluted earnings per share as diluted earnings per share adjusted to exclude the per share impacts of the adjustments applied to net income in calculating adjusted net income.
In calculating our non-GAAP measures, we adjust for the impact of CIPs because it is not considered reflective of our underlying results of operations. Acquisition-related items and special termination benefits are excluded to facilitate comparability to other asset management firms. We adjust for compensation and benefits expense related to funded deferred compensation plans because it is partially offset in other income (expense), net. We adjust for compensation and benefits expense and net income (loss) attributable to redeemable noncontrolling interests to reflect the economics of certain profits interest arrangements. Sales and distribution fees and a portion of investment management fees generally cover sales, distribution and marketing expenses and, therefore, are excluded from adjusted operating revenues. In addition, when calculating adjusted net income and adjusted diluted earnings per share we exclude unrealized investment gains and losses included in investment and other income (losses) because the related investments are generally expected to be held long term.
31

The calculations of adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted earnings per share are as follows:
(in millions)
Three Months Ended
December 31,
20242023
Operating income$219.0$206.5
Add (subtract):
Elimination of operating revenues upon consolidation of investment products*12.511.4
Acquisition-related retention
45.869.1
Compensation and benefits expense from gains on deferred compensation, net0.919.0
Other acquisition-related expenses9.46.8
Amortization of intangible assets
112.685.8
Special termination benefits
0.46.7
Compensation and benefits expense related to minority interests in certain subsidiaries12.211.7
Adjusted operating income$412.8$417.0
Total operating revenues$2,251.6$1,991.1
Add (subtract):
Acquisition-related pass through performance fees
(69.1)(72.6)
Sales and distribution fees
(375.5)(296.4)
Allocation of investment management fees for sales, distribution and marketing expenses
(136.8)(104.4)
Elimination of operating revenues upon consolidation of investment products*12.511.4
Adjusted operating revenues$1,682.7$1,529.1
Operating margin9.7%10.4%
Adjusted operating margin24.5%27.3%
32

(in millions, except per share data)
Three Months Ended
December 31,
20242023
Net income attributable to Franklin Resources, Inc.$163.6 $251.3 
Add (subtract):
Net (income) loss of consolidated investment products*4.2 (2.2)
Acquisition-related retention
45.8 69.1 
Other acquisition-related expenses12.7 10.8 
Amortization of intangible assets
112.6 85.8 
Special termination benefits
0.4 6.7 
Net (gains) losses on deferred compensation plan investments not offset by compensation and benefits expense1.3 (6.0)
Unrealized investment (gains) losses31.5 (49.0)
Interest expense for amortization of debt premium(4.9)(6.4)
Net compensation and benefits expense related to minority interests in certain subsidiaries not offset by net income (loss) attributable to redeemable noncontrolling interests4.1 (2.0)
Net income tax expense of adjustments(50.8)(29.6)
Adjusted net income$320.5 $328.5 
Diluted earnings per share$0.29 $0.50 
Adjusted diluted earnings per share0.59 0.65 
__________________
*The impact of CIPs is summarized as follows:
(in millions)
Three Months Ended
December 31,
20242023
Elimination of operating revenues upon consolidation$(12.5)$(11.4)
Other income (expense), net61.5 (8.6)
Less: income (loss) attributable to noncontrolling interests53.2 (22.2)
Net income (loss)$(4.2)$2.2 
LIQUIDITY AND CAPITAL RESOURCES
Cash flows were as follows: 
Three Months Ended
December 31,
(in millions)20242023
Operating cash flows$(145.2)$(251.9)
Investing cash flows(656.5)(137.6)
Financing cash flows87.9 (159.0)
Net cash used by operating activities decreased during the three months ended December 31, 2024 primarily due higher net income adjusted for non-cash items and an increase in accounts payable and accrued expenses, partially offset by a larger decrease in accrued compensation and benefits. Net cash used in investing activities increased primarily due to net purchases of investments as compared to liquidations in the prior year and higher net purchases of investments by collateralized loan obligations (“CLOs”). Net cash provided by financing activities, as compared to net cash used in financing activities in the prior year, was primarily due to higher net proceeds on debt of CIPs and higher net subscriptions in CIPs by noncontrolling interests.
The assets and liabilities of CIPs attributable to third-party investors do not impact our liquidity and capital resources. We have no right to the CIPs’ assets, other than our direct equity investment in them and investment management and other fees earned from them. The debt holders of the CIPs have no recourse to our assets beyond the level of our direct investment, therefore we bear no other risks associated with the CIPs’ liabilities. Accordingly, the assets and liabilities of CIPs, other than our direct investments in them, are excluded from the amounts and discussion below.
33

Our liquid assets and debt consisted of the following: 
(in millions)December 31,
2024
September 30,
2024
Assets
Cash and cash equivalents$2,765.4 $3,261.1 
Receivables1,252.3 1,261.6 
Investments1,133.8 1,141.7 
Total Liquid Assets$5,151.5 $5,664.4 
Liability
Debt$2,775.8 $2,780.3 
Liquidity
Liquid assets consist of cash and cash equivalents, receivables and certain investments. Cash and cash equivalents at December 31, 2024 primarily consist of money market funds and deposits with financial institutions. Liquid investments consist of investments in sponsored and other funds, direct investments in redeemable CIPs, other equity and debt securities, and time deposits with maturities greater than three months.
We utilize a significant portion of our liquid assets to satisfy operational and regulatory requirements and fund capital contributions to sponsored and other products. Certain of our subsidiaries are required by our internal policy or regulation to maintain minimum levels of cash and/or capital, and may be restricted in their ability to transfer cash to their parent companies. Should we require more capital than is available for use, we could elect to reduce the level of discretionary activities, such as share repurchases or investments in sponsored and other products, we could raise capital through debt or equity issuances, or utilize existing or new credit facilities. These alternatives could result in increased interest expense, decreased dividend or interest income, or other dilution to our earnings.
Capital Resources
We believe that we can meet our present and reasonably foreseeable operating cash needs and future commitments through existing liquid assets, continuing cash flows from operations, amounts available under the credit facility discussed below, the ability to issue debt or equity securities and borrowing capacity under our uncommitted commercial paper private placement program.
In prior fiscal years, we issued senior unsecured unsubordinated notes for general corporate purposes and to redeem outstanding notes. At December 31, 2024, Franklin’s outstanding senior notes had an aggregate principal amount due of $1,600.0 million. The notes have fixed interest rates from 1.600% to 2.950% with interest paid semi-annually and have an aggregate carrying value, inclusive of unamortized discounts and debt issuance costs, of $1,587.4 million. At December 31, 2024, Legg Mason’s outstanding senior notes had an aggregate principal amount due of $1,000.0 million. The notes have fixed interest rates from 4.750% to 5.625% with interest paid semi-annually and have an aggregate carrying value, inclusive of unamortized premium, of $1,188.4 million at December 31, 2024. Franklin unconditionally and irrevocably guarantees all of the outstanding notes issued by Legg Mason. We intend to repay the $400 million 2.850% senior notes due March 2025 from existing cash or other sources of liquidity.
The senior notes contain an optional redemption feature that allows us to redeem each series of notes prior to maturity in whole or in part at any time, at a make-whole redemption price. The indentures governing the senior notes contain limitations on our ability and the ability of our subsidiaries to pledge voting stock or profit participating equity interests in our subsidiaries to secure other debt without similarly securing the notes equally and ratably. In addition, the indentures include requirements that must be met if we consolidate or merge with, or sell all of our assets to, another entity.
We maintain an $800.0 million 5-year revolving credit facility that contains a financial performance covenant requiring that the Company maintain a consolidated net leverage ratio, measured as of the last day of each fiscal quarter, of no greater than 3.25 to 1.00. This facility remains undrawn as of the time of this filing.
We were in compliance with all debt covenants at December 31, 2024.
At December 31, 2024, we had $500.0 million of short-term commercial paper available for issuance under an uncommitted private placement program which has been inactive since 2012 and is unrated.
34

Our ability to access the capital markets in a timely manner depends on a number of factors, including our credit rating, the condition of the global economy, investors’ willingness to purchase our securities, interest rates, credit spreads and the valuation levels of equity markets. If we are unable to access capital markets in a timely manner, our business could be adversely impacted.
Uses of Capital
We expect that our main uses of cash will be to invest in and grow our business including through acquisitions, pay stockholder dividends, invest in our products, pay income taxes and expenses of the business, enhance technology infrastructure and business processes, repurchase shares of our common stock, and repay and service debt. While we expect to continue to repurchase shares to offset dilution from stock-based compensation, and expect to continue to repurchase shares opportunistically from time to time, we will likely spend more of our post-dividend free cash flow investing in our business, including seed capital and acquiring resources to help grow our investment teams and operations.
We typically declare cash dividends on a quarterly basis, subject to approval by our Board of Directors. We declared regular dividends of $0.32 per share during the three months ended December 31, 2024 and $0.31 per share during the three months ended December 31, 2023. We currently expect to continue paying comparable regular dividends on a quarterly basis to holders of our common stock depending upon earnings and other relevant factors.
We maintain a stock repurchase program to manage our equity capital with the objective of maximizing shareholder value. Our stock repurchase program is effected through open-market purchases and private transactions in accordance with applicable laws and regulations, and is not subject to an expiration date. The size and timing of these purchases will depend on business conditions, price, market and other factors, including the terms of any 10b5-1 stock purchase plan that may be in effect at any given time. During the three months ended December 31, 2024, we repurchased 0.3 million shares of our common stock at a cost of $5.8 million and we repurchased 2.4 million shares of our common stock at a cost of $58.8 million in the prior year period. In December 2023, our Board of Directors authorized the repurchase of up to an additional 27.2 million shares of our common stock in either open market or private transactions, for a total of up to 40.0 million shares available for repurchase under the stock repurchase program. At December 31, 2024, 29.7 million shares remained available for repurchase under the authorization approved by our Board of Directors.
We will pay up to $375.0 million related to our acquisition of Putnam between the third and seventh anniversaries of the closing date related to revenue growth targets from the strategic partnership with Great-West and its affiliates which will be recognized in operating income.
We expect to make an additional deferred cash payment related to our acquisition of Lexington of $100.0 million during the third quarter of fiscal year 2025 from existing cash and sources of liquidity.
The funds that we manage have their own resources available for purposes of providing liquidity to meet shareholder redemptions, including securities that can be sold or provided to investors as in-kind redemptions, and lines of credit. Increased liquidity risks and redemptions have required, and may continue to require, increased cash in the form of loans or other lines of credit to help settle redemptions and for other related purposes. While we have no legal or contractual obligation to do so, we have in certain instances voluntarily elected to provide the funds with direct or indirect financial support based on our business objectives. We did not provide financial or other support to our sponsored funds during the three months ended December 31, 2024.
35

CRITICAL ACCOUNTING POLICIES
Our consolidated financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, which require the use of estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. These estimates, judgments and assumptions are affected by our application of accounting policies. Further, concerns about the global economic outlook have adversely affected, and may continue to adversely affect, our business, financial condition and results of operations including the estimates and assumptions made by management. Actual results could differ from the estimates. Described below are the updates to our critical accounting policies disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for fiscal year 2024.
Consolidation
We consolidate our subsidiaries and investment products in which we have a controlling financial interest. We have a controlling financial interest when we own a majority of the voting interest in a voting interest entity or are the primary beneficiary of a variable interest entity (“VIE”). Our VIEs are primarily investment products and our variable interests consist of our equity ownership interests in and investment management fees earned from these products. As of December 31, 2024, we were the primary beneficiary of 66 investment product VIEs.
Business Combinations
Business combinations are accounted for by recognizing the acquired assets, including separately identifiable intangible assets, and assumed liabilities at their acquisition-date estimated fair values. Any excess of the purchase consideration over the acquisition-date fair values of these identifiable assets and liabilities is recognized as goodwill. Goodwill and indefinite-lived intangible assets are tested for impairment annually and when an event occurs or circumstances change that more likely than not reduce the fair value of the related reporting unit or indefinite-lived intangible asset below its carrying value. Definite-lived intangible assets are tested for impairment quarterly.
Subsequent to the annual impairment tests performed as of August 1, 2024, we monitored both macroeconomic and entity-specific factors, including changes in our AUM to determine whether circumstances have changed that would more likely than not reduce the fair value of the reporting unit below its carrying value or indicate that the other indefinite-lived intangible assets might be impaired. We also monitored fluctuations of our common stock per share price to evaluate our market capitalization relative to the reporting unit as a whole. During the three months ended December 31, 2024, there were no events or circumstances which would indicate that goodwill, indefinite-lived intangible assets or definite-lived intangible assets were more likely than not impaired.
While we believe that the assumptions used to estimate fair value in our impairment tests are reasonable and appropriate, future changes in the assumptions could result in recognition of impairment.
Fair Value Measurements
Our investments are primarily recorded at fair value or amounts that approximate fair value on a recurring basis. We use a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based on whether the inputs to those valuation techniques are observable or unobservable.
As of December 31, 2024, Level 3 assets represented 4% of total assets measured at fair value, which primarily related to CIPs’ investments in equity and debt securities. There were insignificant transfers into and no transfers out of Level 3 during the three months ended December 31, 2024.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
During the three months ended December 31, 2024, there were no material changes from the market risk disclosures in our Form 10‑K for the fiscal year ended September 30, 2024.
36

Item 4. Controls and Procedures.
The Company’s management evaluated, with the participation of the Company’s principal executive and principal financial officers, the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of December 31, 2024. Based on their evaluation, the Company’s principal executive and principal financial officers concluded that the Company’s disclosure controls and procedures as of December 31, 2024 were designed and are functioning effectively to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure.
There has been no change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the Company’s fiscal quarter ended December 31, 2024, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
37

PART II – OTHER INFORMATION
Item 1. Legal Proceedings.
For a description of our legal proceedings, please see the description set forth in the “Legal Proceedings” section in Note 10 – Commitments and Contingencies in the notes to consolidated financial statements in Item 1 of Part I of this Form 10Q, which is incorporated herein by reference.
Item 1A. Risk Factors.
There were no material changes from the Risk Factors previously disclosed in our last Annual Report on Form 10-K for fiscal year 2024. These Risk Factors could materially and adversely affect our business, financial condition and results of operations, and our business also could be impacted by other risk factors that are not presently known to us or that we currently consider to be immaterial. Further, our disclosure of a risk should not be interpreted to imply that the risk has not already developed or materialized.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
The following table provides information with respect to the shares of our common stock that we repurchased during the three months ended December 31, 2024.
MonthTotal Number of
Shares Purchased
Average Price
Paid per
Share
Total Number of Shares
Purchased as Part of
Publicly Announced Plans
or Programs
Maximum Number of
Shares that May Yet Be
Purchased Under the Plans
or Programs
October 202432,608 $20.02 32,608 29,905,016 
November 202421,723 20.33 21,723 29,883,293 
December 2024210,683 22.65 210,683 29,672,610 
Total265,014 265,014 
Under our stock repurchase program, which is not subject to an expiration date, we can repurchase shares of our common stock from time to time in the open market and in private transactions in accordance with applicable laws and regulations, including without limitation applicable federal securities laws. In order to pay taxes due in connection with the vesting of employee and executive officer stock and stock unit awards, we may repurchase shares under our program using a net stock issuance method. In December 2023, our Board of Directors authorized the repurchase of up to an additional 27.2 million shares of our common stock in either open market or private transactions, for a total of up to 40.0 million shares available for repurchase under the stock repurchase program.
Item 5. Other Information.
Rule 10b5-1 Trading Plans
During the fiscal quarter ended December 31, 2024, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of Franklin adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408 of Regulation S-K.
Item 6. Exhibits.
The exhibits listed on the Exhibit Index to this Form 10-Q are incorporated herein by reference.
38

EXHIBIT INDEX
 
Exhibit No.Description
3.1
3.2
3.3
3.4
3.5
3.6
31.1
31.2
32.1
32.2
101
The following materials from Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2024, formatted in Inline Extensible Business Reporting Language (iXBRL), include: (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Stockholders’ Equity, (v) the Consolidated Statements of Cash Flows, and (vi) related notes (filed herewith)
104Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101)


39

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 FRANKLIN RESOURCES, INC.
Date:January 31, 2025By:
/s/ Matthew Nicholls
 Matthew Nicholls
 
Executive Vice President, Chief Financial Officer and Chief Operating Officer (Principal Financial Officer)
Date:January 31, 2025By:
/s/ Lindsey H. Oshita
Lindsey H. Oshita
Chief Accounting Officer (Principal Accounting Officer)
40

EXHIBIT 31.1
CERTIFICATION
I, Jennifer M. Johnson, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Franklin Resources, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 

Date:January 31, 2025 
  /s/    Jennifer M. Johnson
 Jennifer M. Johnson
 President and Chief Executive Officer (Principal Executive Officer)



EXHIBIT 31.2
CERTIFICATION
I, Matthew Nicholls, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Franklin Resources, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  
Date:January 31, 2025 
/s/    Matthew Nicholls
 Matthew Nicholls
 Executive Vice President, Chief Financial Officer and Chief Operating Officer (Principal Financial Officer)



EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002 (FURNISHED HEREWITH)
I, Jennifer M. Johnson, President and Chief Executive Officer of Franklin Resources, Inc. (the “Company”), certify, as of the date hereof and solely for purposes of and pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1.The Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended December 31, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.
 
Date:January 31, 2025 
/s/    Jennifer M. Johnson
 Jennifer M. Johnson
 President and Chief Executive Officer (Principal Executive Officer)



EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002 (FURNISHED HEREWITH)
I, Matthew Nicholls, Executive Vice President, Chief Financial Officer and Chief Operating Officer of Franklin Resources, Inc. (the “Company”), certify, as of the date hereof and solely for purposes of and pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1.The Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended December 31, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.
 
Date:January 31, 2025 
/s/    Matthew Nicholls
 Matthew Nicholls
 Executive Vice President, Chief Financial Officer and Chief Operating Officer (Principal Financial Officer)



v3.24.4
Document and Entity Information - shares
3 Months Ended
Dec. 31, 2024
Jan. 23, 2025
Document And Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2024  
Document Transition Report false  
Entity File Number 001-09318  
Entity Registrant Name FRANKLIN RESOURCES, INC.  
Entity Central Index Key 0000038777  
Current Fiscal Year End Date --09-30  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 13-2670991  
Entity Address, Address Line One One Franklin Parkway  
Entity Address, City or Town San Mateo  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94403  
City Area Code 650  
Local Phone Number 312-2000  
Title of 12(b) Security Common Stock, par value $0.10 per share  
Trading Symbol BEN  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   525,397,977
v3.24.4
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating Revenues    
Operating revenues $ 2,251.6 $ 1,991.1
Operating Expenses    
Compensation and benefits 991.4 968.3
Sales, distribution and marketing 512.3 400.8
Information systems and technology 156.0 131.0
Occupancy 75.1 66.7
Amortization of intangible assets 112.6 85.8
General, administrative and other 185.2 132.0
Total operating expenses 2,032.6 1,784.6
Operating Income 219.0 206.5
Other Income (Expenses)    
Other Nonoperating Income (Expense) 10.5 173.2
Interest expense (23.1) (18.8)
Other Nonoperating Expense 0.2  
Nonoperating Income (Expense) 94.2 124.7
Income before taxes 313.2 331.2
Taxes on income 81.1 74.9
Net Income 232.1 256.3
Less: net income (loss) attributable to    
Redeemable noncontrolling interests 49.6 9.5
Nonredeemable noncontrolling interests 18.9 (4.5)
Net income attributable to Franklin Resources, Inc. $ 163.6 $ 251.3
Earnings per Share    
Basic $ 0.29 $ 0.50
Diluted $ 0.29 $ 0.50
CIPs [Member]    
Other Income (Expenses)    
Other Nonoperating Income (Expense) $ 114.1 $ (23.8)
Other Nonoperating Expense (7.3) (5.9)
Less: net income (loss) attributable to    
Redeemable noncontrolling interests 38.9 (2.9)
Investment management fees [Member]    
Operating Revenues    
Operating revenues 1,799.3 1,652.2
Sales and distribution fees [Member]    
Operating Revenues    
Operating revenues 375.5 296.4
Shareholder servicing fees [Member]    
Operating Revenues    
Operating revenues 63.5 32.5
Other [Member]    
Operating Revenues    
Operating revenues $ 13.3 $ 10.0
v3.24.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net Income $ 232.1 $ 256.3
Other Comprehensive Income (Loss)    
Currency translation adjustments, net of tax (105.1) 59.1
Net unrealized gains (losses) on defined benefit plans, net of tax 0.3 (0.1)
Total other comprehensive income (loss) (104.8) 59.0
Total comprehensive income 127.3 315.3
Less: comprehensive income (loss) attributable to    
Redeemable noncontrolling interests 49.6 9.5
Nonredeemable noncontrolling interests 18.9 (4.5)
Comprehensive Income Attributable to Franklin Resources, Inc. $ 58.8 $ 310.3
v3.24.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Assets    
Receivables $ 1,393.8 $ 1,479.1
Investments 2,392.5 2,338.4
Total investments, at fair value 806.9 838.0
Property and equipment, net 977.7 946.4
Goodwill 6,193.9 6,211.4
Intangible assets, net 4,677.3 4,802.1
Operating lease right-of-use assets 795.1 823.3
Other 417.2 420.0
Total Assets 32,390.0 32,464.5
Liabilities    
Compensation and benefits 1,131.8 1,801.3
Accounts payable and accrued expenses 585.0 551.5
Income taxes 461.4 406.4
Debt 2,775.8 2,780.3
Deferred tax liabilities 279.8 284.9
Operating lease liabilities 946.2 965.1
Other 953.8 907.4
Total liabilities 17,050.3 17,899.7
Commitments and Contingencies (Note 10)
Redeemable Noncontrolling Interests 2,106.0 1,321.8
Stockholders’ Equity    
Preferred stock, $1.00 par value, 1,000,000 shares authorized; none issued 0.0 0.0
Common stock, $0.10 par value, 1,000,000,000 shares authorized; 523,967,899 and 523,596,548 shares issued and outstanding at December 31, 2024 and September 30, 2024 52.4 52.4
Additional Paid in Capital, Common Stock 1,014.9 947.6
Retained earnings 11,919.1 11,927.6
Accumulated other comprehensive loss (524.3) (419.5)
Total Franklin Resources, Inc. stockholders’ equity 12,462.1 12,508.1
Nonredeemable noncontrolling interests 771.6 734.9
Total stockholders’ equity 13,233.7 13,243.0
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity 32,390.0 32,464.5
CIPs [Member]    
Assets    
Cash and cash equivalents 837.1 1,099.4
Receivables 141.5 217.5
Total investments, at fair value 11,897.4 11,034.9
Total Assets 12,876.0 12,351.8
Liabilities    
Accounts payable and accrued expenses 861.2 861.3
Debt 9,055.3 9,341.5
Other 11.2 39.9
Total liabilities 9,927.7 10,242.7
Redeemable Noncontrolling Interests 1,466.5 687.8
Stockholders’ Equity    
Total Franklin Resources, Inc. stockholders’ equity 1,098.0 1,080.9
Nonredeemable noncontrolling interests 383.8 340.4
Total stockholders’ equity 1,481.8 1,421.3
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity 12,876.0 12,351.8
Franklin Resources, Inc. [Member]    
Assets    
Cash and cash equivalents $ 2,808.0 $ 3,309.5
v3.24.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Statement of Financial Position [Abstract]    
Investments, at fair value $ 806.9 $ 838.0
Preferred Stock, Par or Stated Value Per Share $ 1.00 $ 1.00
Preferred Stock, Shares Authorized 1,000,000 1,000,000
Common Stock, Par or Stated Value Per Share $ 0.10 $ 0.10
Common Stock, Shares Authorized 1,000,000,000 1,000,000,000
Common Stock, Shares, Issued 523,967,899 523,596,548
Common Stock, Shares, Outstanding 523,967,899 523,596,548
v3.24.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Stockholders' Equity [Member]
Nonredeemable Noncontrolling Interests [Member]
Beginning balance - Shares at Sep. 30, 2023   495.9          
Beginning balance at Sep. 30, 2023   $ 49.6 $ 0.0 $ 12,376.6 $ (509.3) $ 11,916.9  
Beginning balance at Sep. 30, 2023             $ 630.9
Beginning balance at Sep. 30, 2023 $ 12,547.8            
Stockholders' Equity [Roll Forward]              
Net income attributable to Franklin Resources, Inc. 251.3     251.3   251.3  
Nonredeemable noncontrolling interests (4.5)           (4.5)
Net income 246.8            
Other comprehensive income (loss) 59.0       59.0 59.0  
Dividends declared on common stock (167.6)     (167.6)   (167.6)  
Repurchase of common stock - Shares   (2.4)          
Repurchase of common stock - Amount (58.8) $ (0.2) (66.6) 8.0   (58.8)  
Issuance of common stock - Shares   1.2          
Issuance of common stock - Amount 26.8 $ 0.1 26.7     26.8  
Stock-based compensation 39.9   39.9     39.9  
Net subscriptions (distributions) and other 9.6           9.6
Adjustment to fair value (65.9)     (65.9)   (65.9)  
Ending balance - Shares at Dec. 31, 2023   494.7          
Ending balance at Dec. 31, 2023   $ 49.5 0.0 12,402.4 (450.3) 12,001.6  
Ending balance at Dec. 31, 2023             636.0
Ending balance at Dec. 31, 2023 12,637.6            
Beginning balance - Shares at Sep. 30, 2024   523.6          
Beginning balance at Sep. 30, 2024 12,508.1 $ 52.4 947.6 11,927.6 (419.5) 12,508.1  
Beginning balance at Sep. 30, 2024 734.9           734.9
Beginning balance at Sep. 30, 2024 13,243.0            
Stockholders' Equity [Roll Forward]              
Net income attributable to Franklin Resources, Inc. 163.6     163.6   163.6  
Nonredeemable noncontrolling interests 18.9           18.9
Net income 182.5            
Other comprehensive income (loss) (104.8)       (104.8) (104.8)  
Dividends declared on common stock (173.6)     (173.6)   (173.6)  
Repurchase of common stock - Shares   (0.3)          
Repurchase of common stock - Amount (5.8) $ 0.0 (5.8) 0.0   (5.8)  
Issuance of common stock - Shares   0.7          
Issuance of common stock - Amount 21.5 $ 0.0 21.5     21.5  
Stock-based compensation 51.6   51.6     51.6  
Net subscriptions (distributions) and other 13.1           13.1
Adjustment to fair value of redeemable noncontrolling interests 4.7           4.7
Adjustment to fair value 1.5     1.5   1.5  
Ending balance - Shares at Dec. 31, 2024   524.0          
Ending balance at Dec. 31, 2024 12,462.1 $ 52.4 $ 1,014.9 $ 11,919.1 $ (524.3) $ 12,462.1  
Ending balance at Dec. 31, 2024 771.6           $ 771.6
Ending balance at Dec. 31, 2024 $ 13,233.7            
v3.24.4
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Dividends declared per share $ 0.32 $ 0.31
v3.24.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Net cash used in operating activities    
Net Income $ 232.1 $ 256.3
Adjustments to reconcile net income to net cash used in operating activities:    
Stock-based compensation 73.2 66.8
Amortization of deferred sales commissions 20.2 13.4
Depreciation and other amortization 30.2 25.7
Amortization of intangible assets 112.6 85.8
Net losses (gains) on investments 57.1 (60.1)
Income (losses) from investments in equity method investees 7.6 (56.9)
Net (gains) losses on investments of consolidated investment products (87.2) 66.0
Net purchase of investments by consolidated investment products (83.9) (147.5)
Deferred income taxes 1.6 (57.7)
Other 31.6 31.6
Changes in operating assets and liabilities:    
Decrease (increase) in receivables and other assets 10.2 (36.7)
Decrease in investments, net 1.1 0.2
Decrease in accrued compensation and benefits (654.3) (508.0)
Increase in income taxes payable 55.0 107.9
Increase (decrease) in accounts payable, accrued expenses and other liabilities 95.0 (39.7)
Increase (decrease) in accounts payable and accrued expenses of consolidated investment products (47.3) 1.0
Net cash used in operating activities (145.2) (251.9)
Net cash used in investing activities    
Purchase of investments (458.0) (267.4)
Liquidation of investments 168.4 317.6
Purchase of investments by consolidated collateralized loan obligations (1,291.1) (794.0)
Liquidation of investments by consolidated collateralized loan obligations 1,001.1 697.0
Additions of property and equipment, net (71.8) (19.5)
Payments of deferred consideration liability 0.0 (60.8)
Net deconsolidation of investment products (5.1) (10.5)
Net cash used in investing activities (656.5) (137.6)
Net cash provided by (used in) financing activities    
Dividends paid on common stock (166.2) (155.7)
Repurchase of common stock (5.8) (58.8)
Proceeds from repurchase agreement 38.9 0.0
Payments on repurchase agreement (29.6) 0.0
Proceeds from debt of consolidated investment products 794.4 39.8
Payments on debt of consolidated investment products (714.9) (22.0)
Payments on contingent consideration liabilities (0.7) 0.0
Noncontrolling interests 171.8 37.7
Net cash provided by (used in) financing activities 87.9 (159.0)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations (50.0) 25.7
Decrease in cash and cash equivalents (763.8) (522.8)
Cash and cash equivalents, beginning of period 4,408.9 4,402.4
Cash and Cash Equivalents, End of Period 3,645.1 3,879.6
Supplemental Disclosure of Cash Flow Information    
Cash paid for income taxes 27.9 26.8
Cash paid for interest 9.9 10.6
Cash paid for interest by consolidated investment products $ 202.0 $ 161.6
v3.24.4
Basis of Presentation
3 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation Basis of Presentation
The unaudited interim financial statements of Franklin Resources, Inc. (“Franklin”) and its consolidated subsidiaries (collectively, the “Company”) included herein have been prepared in accordance with the instructions to Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Under these rules and regulations, some information and footnote disclosures normally included in financial statements prepared under accounting principles generally accepted in the United States of America have been shortened or omitted. Management believes that all adjustments necessary for a fair statement of the financial position and the results of operations for the periods shown have been made. All adjustments are normal and recurring. Management also believes that the accounting estimates are appropriate, and the resulting balances are reasonable; however, due to the inherent uncertainties in making estimates, actual amounts may differ from these estimates. These financial statements should be read together with the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2024 (“fiscal year 2024”).
v3.24.4
New Accounting Guidance
3 Months Ended
Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]  
New Accounting Guidance New Accounting Guidance
Accounting Guidance Not Yet Adopted
In November 2023, the Financial Accounting Standards Board (“FASB”) issued an amendment to the existing segment reporting guidance. The amendment requires annual and interim disclosures of significant segment expenses that are regularly provided to the chief operating decision maker by reportable segment and clarifies that single reportable segment entities are required to apply all existing segment disclosures in the guidance. The Company will adopt the annual disclosures in its Annual Report on Form 10-K for the fiscal year ending September 30, 2025 and interim disclosure in its Quarterly report on Form 10-Q for the quarter ending December 31, 2025.
There were no other significant updates to the new accounting guidance that the Company has not yet adopted as disclosed in its Form 10-K for fiscal year 2024.
v3.24.4
Earnings per Share
3 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Earnings per Share Earnings per Share
The components of basic and diluted earnings per share were as follows: 
(in millions, except per share data)
Three Months Ended
December 31,
20242023
Net income attributable to Franklin Resources, Inc.$163.6 $251.3 
Less: allocation of earnings to participating nonvested stock and stock unit awards
15.4 9.7 
Net Income Available to Common Stockholders$148.2 $241.6 
Weighted-average shares outstanding – basic517.4 487.0 
Dilutive effect of nonparticipating nonvested stock unit awards
0.8 0.9 
Weighted-Average Shares Outstanding – Diluted518.2 487.9 
Earnings per Share
Basic$0.29 $0.50 
Diluted0.29 0.50 
There were no nonparticipating nonvested stock unit awards excluded from the calculation of diluted earnings per share because their effect would have been antidilutive for the three months ended December 31, 2024 and such awards were insignificant for the three months ended December 31, 2023.
v3.24.4
Revenues
3 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenues Revenues
Operating revenues by geographic area were as follows:
(in millions)United StatesLuxembourgAsia-PacificAmericas
Excluding
United
States
Europe,
Middle East
and Africa,
Excluding
Luxembourg
Total
for the three months ended December 31, 2024
Investment management fees
$1,361.4 $223.9 $75.8 $53.6 $84.6 $1,799.3 
Sales and distribution fees
267.1 93.4 4.9 10.0 0.1 375.5 
Shareholder servicing fees
55.1 8.0 0.4 — — 63.5 
Other
13.1 — 0.2 — — 13.3 
Total
$1,696.7 $325.3 $81.3 $63.6 $84.7 $2,251.6 
(in millions)United StatesLuxembourgAsia-PacificAmericas
Excluding
United
States
Europe,
Middle East
and Africa,
Excluding
Luxembourg
Total
for the three months ended December 31, 2023
Investment management fees
$1,260.6 $191.7 $68.5 $51.5 $79.9 $1,652.2 
Sales and distribution fees
205.7 76.5 4.6 9.6 — 296.4 
Shareholder servicing fees
24.2 7.6 0.6 0.1 — 32.5 
Other
9.0 0.5 0.2 — 0.3 10.0 
Total
$1,499.5 $276.3 $73.9 $61.2 $80.2 $1,991.1 
Operating revenues are attributed to geographic areas based on the locations of the subsidiaries that provide the services, which may differ from the regions in which the related investment products are sold.
Revenues earned from sponsored funds were 83% of the Company’s total operating revenues for the three months ended December 31, 2024 and 2023.
v3.24.4
Investments
3 Months Ended
Dec. 31, 2024
Investments [Abstract]  
Investments Investments
The disclosures below include details of the Company’s investments, excluding those of consolidated investment products (“CIPs”). See Note 7 Consolidated Investment Products for information related to the investments held by these entities.
Investments consisted of the following:
(in millions)December 31,
2024
September 30,
2024
Investments, at fair value
Sponsored funds and separate accounts$469.1 $509.1 
Investments related to long-term incentive plans266.3 271.6 
Other equity and debt investments71.5 57.3 
Total investments, at fair value806.9 838.0 
Investments in equity method investees1,175.5 1,219.7 
Other investments410.1 280.7 
Total$2,392.5 $2,338.4 
The Company has entered into repurchase agreements with a third-party financing company for certain investments held by the Company. As of December 31, 2024 and September 30, 2024, other liabilities includes repurchase agreements of $116.5 million and $111.4 million with investments of $122.5 million and $121.7 million in carrying value pledged as collateral. The repurchase agreements have contractual maturity dates ranging between 2030 to 2038.
v3.24.4
Fair Value Measurements
3 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The disclosures below include details of the Company’s fair value measurements, excluding those of CIPs. See Note 7 – Consolidated Investment Products for information related to fair value measurements of the assets and liabilities of these entities.
The assets and liabilities measured at fair value on a recurring basis were as follows: 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of December 31, 2024
Assets
Investments, at fair value
Sponsored funds and separate accounts$257.6 $171.3 $4.7 $35.5 $469.1 
Investments related to long-term incentive plans237.1 — — 29.2 266.3 
Other equity and debt investments17.5 14.0 1.6 38.4 71.5 
Total Assets Measured at Fair Value$512.2 $185.3 $6.3 $103.1 $806.9 
Liabilities
Securities sold short$244.9 $— $— $— $244.9 
Contingent consideration liabilities— — 27.5 — 27.5 
Total Liabilities Measured at Fair Value$244.9 $ $27.5 $ $272.4 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of September 30, 2024
Assets
Investments, at fair value
Sponsored funds and separate accounts$306.3 $157.4 $5.2 $40.2 $509.1 
Investments related to long-term incentive plans242.5 — — 29.1 271.6 
Other equity and debt investments4.1 11.1 2.6 39.5 57.3 
Total Assets Measured at Fair Value$552.9 $168.5 $7.8 $108.8 $838.0 
Liabilities
Securities sold short$178.1 $— $— $— $178.1 
Contingent consideration liabilities— — 28.2 — 28.2 
Total Liabilities Measured at Fair Value$178.1 $ $28.2 $ $206.3 
Investments for which fair value was estimated using reported NAV as a practical expedient primarily consist of nonredeemable private equity, debt and infrastructure funds, and redeemable alternative credit, global equity, private real estate funds and alternatives. These investments were as follows:
(in millions)December 31,
2024
September 30,
2024
Nonredeemable investments1
Investments with known liquidation periods$29.7 $32.4 
Investments with unknown liquidation periods15.7 16.1 
Redeemable investments2
57.7 60.3 
Unfunded commitments15.6 14.0 
_______________
1The investments are expected to be returned through distributions over the life of the funds as a result of liquidations of the funds’ underlying assets. Investments with known liquidation periods have an expected weighted-average life of 1.9 years at December 31, 2024 and September 30, 2024.
2Investments are redeemable on a semi-monthly, monthly and quarterly basis.
Financial instruments that were not measured at fair value were as follows:
(in millions)Fair Value
Level
December 31, 2024September 30, 2024
Carrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
Financial Assets
Cash and cash equivalents1$2,808.0 $2,808.0 $3,309.5 $3,309.5 
Other investments
Time deposits28.7 8.7 9.8 9.8 
Equity securities3401.4 401.4 270.9 270.9 
Financial Liability
Debt2$2,775.8 $2,315.0 $2,780.3 $2,387.0 
v3.24.4
Consolidated Investment Products
3 Months Ended
Dec. 31, 2024
Consolidated Investment Products [Abstract]  
Consolidated Investment Products Consolidated Investment Products
CIPs consist of mutual and other investment funds, limited partnerships and similar structures and CLOs, all of which are sponsored by the Company, and include both voting interest entities and variable interest entities (“VIEs”). The Company had 75 CIPs, including 22 CLOs, as of December 31, 2024 and 77 CIPs, including 22 CLOs, as of September 30, 2024.
The balances related to CIPs included in the Company’s consolidated balance sheets were as follows:
(in millions)December 31,
2024
September 30,
2024
Assets
Cash and cash equivalents$837.1 $1,099.4 
Receivables141.5 217.5 
Investments, at fair value11,897.4 11,034.9 
Total Assets$12,876.0 $12,351.8 
Liabilities
Accounts payable and accrued expenses$861.2 $861.3 
Debt9,055.3 9,341.5 
Other liabilities11.2 39.9 
Total liabilities9,927.7 10,242.7 
Redeemable Noncontrolling Interests1,466.5 687.8 
Stockholders Equity
Franklin Resources, Inc.’s interests1,098.0 1,080.9 
Nonredeemable noncontrolling interests383.8 340.4 
Total stockholders’ equity1,481.8 1,421.3 
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders Equity
$12,876.0 $12,351.8 
The CIPs did not have a significant impact on net income attributable to the Company during the three months ended December 31, 2024 and 2023.
The Company has no right to the CIPs’ assets, other than its direct equity investments in them and investment management and other fees earned from them. The debt holders of the CIPs have no recourse to the Company’s assets beyond the level of its direct investment; therefore the Company bears no other risks associated with the CIPs’ liabilities.
Fair Value Measurements
Assets of CIPs measured at fair value on a recurring basis were as follows: 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of December 31, 2024
Assets
Cash and cash equivalents of CLOs$519.3 $— $— $— $519.3 
Receivables of CLOs— 80.8 — — 80.8 
Investments
Equity and debt securities485.5 1,501.9 573.5 124.0 2,684.9 
Loans— 9,212.3 0.2 — 9,212.5 
Total Assets Measured at Fair Value$1,004.8 $10,795.0 $573.7 $124.0 $12,497.5 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of September 30, 2024
Assets
Cash and cash equivalents of CLOs$764.3 $— $— $— $764.3 
Receivables of CLOs— 149.6 — — 149.6 
Investments
Equity and debt securities229.7 889.4 550.1 187.1 1,856.3 
Loans— 9,178.1 0.5 — 9,178.6 
Total Assets Measured at Fair Value$994.0 $10,217.1 $550.6 $187.1 $11,948.8 
Investments for which fair value was estimated using reported NAV as a practical expedient consist of a redeemable U.S. equity fund, a redeemable global hedge fund and nonredeemable private debt funds. These investments were as follows:
(in millions)December 31,
2024
September 30,
2024
Nonredeemable investments1
Investments with unknown liquidation periods$53.8 $49.0 
Redeemable investments2
70.2 138.1 
Unfunded commitments3
42.8 42.8 
_______________
1The investments are expected to be returned through distributions over the life of the funds as a result of liquidations of the funds’ underlying assets.
2Investments are redeemable on a monthly basis and liquidation periods are unknown.
3Of the total unfunded commitments, the Company was contractually obligated to fund $9.9 million based on its ownership percentage in the CIPs, at December 31, 2024 and September 30, 2024.

Changes in Level 3 assets were as follows: 
(in millions)Equity and Debt
Securities
for the three months ended December 31, 2024
Balance at October 1, 2024$550.1 
Gains included in investment and other income (losses) of consolidated investment products, net22.0 
Purchases9.2 
Sales
(11.6)
Net consolidations3.8 
Balance at December 31, 2024$573.5 
Change in unrealized gains included in net income relating to assets held at December 31, 2024$22.3 
(in millions)Equity and Debt
Securities
LoansTotal 
Level 3
Assets
for the three months ended December 31, 2023
Balance at October 1, 2023$584.9 $— $584.9 
Losses included in investment and other income (losses) of consolidated investment products, net(38.1)— (38.1)
Purchases3.8 — 3.8 
Sales
(0.2)— (0.2)
Transfers into Level 31.1 0.6 1.7 
Balance at December 31, 2023$551.5 $0.6 $552.1 
Change in unrealized losses included in net income relating to assets held at December 31, 2023$(37.8)$— $(37.8)
Valuation techniques and significant unobservable inputs used in Level 3 fair value measurements were as follows:
(in millions)
as of December 31, 2024Fair ValueValuation TechniqueSignificant Unobservable Inputs
Range (Weighted Average1)
Equity and debt securities$302.2 Market comparable companiesEnterprise value/ Revenue multiple
1.4–28.7 (11.0)
Discount for lack of marketability
5.8%–11.8% (8.0%)
219.1 Market pricingPrivate sale pricing
$0.01–$1,120.00 ($82.93) per share
Discount for lack of marketability
9.7%–13.3% (10.4%)
52.2 Discounted cash flowDiscount rate
6.3%–6.4% (6.3%)
(in millions)
as of September 30, 2024Fair ValueValuation TechniqueSignificant Unobservable Inputs
Range (Weighted Average1)
Equity and debt securities$291.6 Market comparable companiesEnterprise value/ Revenue multiple
1.2–22.8 (10.9)
Discount for lack of marketability
0.1%–10.4% (8.1%)
214.5 Market pricingPrivate sale pricing
$0.01–$1,000.00 ($73.04) per share
Discount for lack of marketability
9.8%–17.5% (11.5%)
44.0 Discounted cash flowDiscount rate6.8%
__________________
1Based on the relative fair value of the instruments.

If the relevant significant inputs used in the market-based valuations, other than discount for lack of marketability, were independently higher (lower) as of December 31, 2024, the resulting fair value of the assets would be higher (lower). If the relevant significant inputs used in the discounted cash flow, as well as the discount for lack of marketability used in the market-based valuations, were independently higher (lower) as of December 31, 2024, the resulting fair value of the assets would be lower (higher).
Financial instruments of CIPs that were not measured at fair value were as follows:
(in millions)Fair Value
Level
December 31, 2024September 30, 2024
Carrying
Value
Estimated
Fair Value
Carrying
Value
Estimated
Fair Value
Financial Asset
Cash and cash equivalents1$317.8 $317.8 $335.1 $335.1 
Financial Liabilities
Debt of CLOs1
2 or 3$9,055.3 $8,858.1 $9,341.5 $9,167.3 
__________________
1Substantially all was Level 2.
Debt
Debt of CLOs totaled $9,055.3 million and $9,341.5 million at December 31, 2024 and September 30, 2024. The debt had fixed and floating interest rates ranging from 2.39% to 13.68% with a weighted-average effective interest rate of 7.30% at December 31, 2024, and from 2.39% to 13.73% with a weighted-average effective interest rate of 7.36% at September 30, 2024. The floating rates were based on the Secured Overnight Financing Rate.
The contractual maturities for the debt of CLOs at December 31, 2024 were as follows:
(in millions)
for the fiscal years ending September 30,Amount
2025 (remainder of year)$120.1 
2026— 
2027— 
2028— 
2029— 
Thereafter8,935.2 
Total$9,055.3 
Collateralized Loan Obligations
The unpaid principal balance and fair value of the investments of CLOs were as follows:
(in millions)December 31,
2024
September 30,
2024
Unpaid principal balance$9,420.8 $9,371.9 
Difference between unpaid principal balance and fair value(24.1)(19.8)
Fair Value$9,396.7 $9,352.1 
Investments 90 days or more past due were immaterial at December 31, 2024 and September 30, 2024.
The Company recognized $11.7 million and $20.8 million of net gains during the three months ended December 31, 2024 and 2023, related to its own economic interests in the CLOs. The aggregate principal amount due of the debt of CLOs was $9,015.0 million and $9,282.8 million at December 31, 2024 and September 30, 2024.
v3.24.4
Redeemable Noncontrolling Interests
3 Months Ended
Dec. 31, 2024
Noncontrolling Interest [Abstract]  
Noncontrolling Interest Disclosure Redeemable Noncontrolling Interests
Changes in redeemable noncontrolling interests were as follows:
(in millions)20242023
CIPsMinority InterestsTotalCIPsMinority InterestsTotal
for the three months ended December 31,
Balance at beginning of period$687.8 $634.0 $1,321.8 $580.1 $446.0 $1,026.1 
Net income (loss)38.9 10.7 49.6 (2.9)12.4 9.5 
Net subscriptions (distributions) and other175.6 (3.7)171.9 38.1 (1.1)37.0 
Net consolidations (deconsolidations)564.2 — 564.2 (60.0)— (60.0)
Adjustment to fair value— (1.5)(1.5)— 65.9 65.9 
Balance at End of Period$1,466.5 $639.5 $2,106.0 $555.3 $523.2 $1,078.5 
v3.24.4
Nonconsolidated Variable Interest Entities
3 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nonconsolidated Variable Interest Entities Nonconsolidated Variable Interest Entities
VIEs for which the Company is not the primary beneficiary consist of sponsored funds and other investment products in which the Company has an equity ownership interest. The Company’s maximum exposure to loss from these VIEs consists of equity investments, investment management and other fee receivables as follows: 
(in millions)December 31,
2024
September 30,
2024
Investments$1,106.8 $1,074.4 
Receivables219.8 226.0 
Total$1,326.6 $1,300.4 
While the Company has no legal or contractual obligation to do so, it routinely makes cash investments in the course of launching sponsored funds. As it has done in the past, the Company also may voluntarily elect to provide its sponsored funds with additional direct or indirect financial support based on its business objectives. The Company did not provide financial or other support to its sponsored funds assessed as VIEs during the three months ended December 31, 2024 or fiscal year 2024.
v3.24.4
Commitments and Contingencies
3 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Proceedings
India Credit Fund Closure Matters. During the three months ended December 31, 2024, there were no significant changes from the disclosure in the Form 10‑K for the fiscal year ended September 30, 2024.
Western Asset Management Investigations. As previously disclosed, the Company launched an internal investigation into certain trade allocations of treasury derivatives in select Western Asset Management (“WAM”) managed accounts. WAM received notification of parallel investigations by the SEC and the U.S. Department of Justice (“DOJ”). WAM also received notice of an investigation into these trading activities by the CFTC. As previously disclosed, Ken Leech, the former co-Chief Investment Officer of WAM, received a “Wells Notice” from the staff of the SEC in August 2024 and is now on administrative leave. On November 25, 2024, the SEC filed a complaint in the United States District Court for the Southern District of New York against Mr. Leech alleging violations of certain laws related to trade allocations. Concurrently, the DOJ filed an indictment with the United States District Court for the Southern District of New York against Mr. Leech for similar allegations and for false statements made to the SEC. The Company and WAM have fully cooperated, and will continue to fully cooperate with these investigations.
Blockchain Litigation. The Company, two of its subsidiaries, the Company’s CEO, and an individual employee (collectively the “Defendants”) are named as defendants in litigation pending in the United States District Court for the Northern District of California. The action was filed in November 2021 by Blockchain Innovation, LLC (the “Plaintiff”) and relates to a startup entity in which the Company subsidiary Defendant previously owned all voting shares. The Plaintiff asserts it acquired the assets of the startup entity and claims that the Defendants improperly wound down the startup and misappropriated its intellectual property. The action asserts claims for alleged breaches of fiduciary duties, aiding and abetting breaches of fiduciary duty, breach of contract, and misappropriation of trade secrets. The Plaintiff is seeking various forms of relief, including, among other things, compensatory damages, punitive and exemplary damages, and an injunction including to prevent the Defendants from using any allegedly misappropriated trade secrets and technology. The trial is scheduled to begin in March 2025.
The Defendants believe the claims are without merit and are vigorously defending against the action. The Company cannot predict the outcome of this lawsuit and is unable to estimate any reasonably possible loss or range of loss (including with respect to indemnification of the individual Defendants) that may potentially result if the Plaintiff were to prevail on any of its claims.
Other Litigation and Regulatory Matters. The Company is from time to time involved in other litigation relating to claims arising in the normal course of business. Management is of the opinion that the ultimate resolution of such claims will not materially affect the Company’s business, financial position, results of operations or liquidity. In management’s opinion, an adequate accrual has been made as of December 31, 2024 to provide for any probable losses that may arise from such matters for which the Company could reasonably estimate an amount.
Indemnifications and Guarantees
In the ordinary course of business or in connection with certain acquisition agreements, the Company enters into contracts that provide for indemnifications by the Company in certain circumstances. In addition, certain Company entities guarantee certain financial and performance-related obligations of various Franklin subsidiaries. The Company is also subject to certain legal requirements and agreements providing for indemnifications of directors, officers and personnel against liabilities and expenses they may incur under certain circumstances in connection with their service. The terms of these indemnities and guarantees vary pursuant to applicable facts and circumstances, and from agreement to agreement. Future payments for claims against the Company under these indemnities or guarantees could negatively impact the Company’s financial condition. In management’s opinion, no material loss was deemed probable or reasonably possible pursuant to such indemnification agreements and/or guarantees as of December 31, 2024.
Other Commitments and Contingencies
At December 31, 2024, there were no other material changes in the other commitments and contingencies as reported in the Company’s Annual Report on Form 10-K for fiscal year 2024.
v3.24.4
Stock-Based Compensation
3 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Stock and stock unit award activity was as follows:
(shares in thousands)Time-Based
Shares
Performance-
Based Shares
Total
Shares
Weighted-
Average
Grant-Date
Fair Value
for the three months ended December 31, 2024
Nonvested balance at October 1, 202416,594 3,314 19,908 $24.03 
Granted7,812 169 7,981 20.73 
Vested(524)(166)(690)26.34 
Forfeited/canceled(226)(72)(298)24.95 
Nonvested Balance at December 31, 202423,656 3,245 26,901 $22.98 
Total unrecognized compensation expense related to nonvested stock and stock unit awards was $310.4 million at December 31, 2024. This expense is expected to be recognized over a remaining weighted-average vesting period of 2.1 years.
v3.24.4
Investment and Other Income, Net
3 Months Ended
Dec. 31, 2024
Other Income and Expenses [Abstract]  
Other Income (Expenses) Investment and Other Income, Net
Investment and other income, net consisted of the following:
 
Three Months Ended
December 31,
(in millions)20242023
Dividend and interest income$43.1 $54.8 
Gains (losses) on investments, net(57.1)60.1 
Income (losses) from investments in equity method investees(7.6)56.9 
Gains (losses) on derivatives, net6.6 (8.2)
Rental income11.2 10.8 
Foreign currency exchange gains (losses), net14.5 (7.4)
Other, net(0.2)6.2 
Investment and other income, net$10.5 $173.2 
Net gains (losses) recognized on equity securities measured at fair value and trading debt securities that were held by the Company were $(87.2) million for the three months ended December 31, 2024 and $68.5 million for the three months ended December 31, 2023.
v3.24.4
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure    
Net income attributable to Franklin Resources, Inc. $ 163.6 $ 251.3
v3.24.4
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.4
Earnings per Share (Tables)
3 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Components of basic and diluted earnings per share
The components of basic and diluted earnings per share were as follows: 
(in millions, except per share data)
Three Months Ended
December 31,
20242023
Net income attributable to Franklin Resources, Inc.$163.6 $251.3 
Less: allocation of earnings to participating nonvested stock and stock unit awards
15.4 9.7 
Net Income Available to Common Stockholders$148.2 $241.6 
Weighted-average shares outstanding – basic517.4 487.0 
Dilutive effect of nonparticipating nonvested stock unit awards
0.8 0.9 
Weighted-Average Shares Outstanding – Diluted518.2 487.9 
Earnings per Share
Basic$0.29 $0.50 
Diluted0.29 0.50 
v3.24.4
Revenues (Tables)
3 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Operating revenues by geographic area
Operating revenues by geographic area were as follows:
(in millions)United StatesLuxembourgAsia-PacificAmericas
Excluding
United
States
Europe,
Middle East
and Africa,
Excluding
Luxembourg
Total
for the three months ended December 31, 2024
Investment management fees
$1,361.4 $223.9 $75.8 $53.6 $84.6 $1,799.3 
Sales and distribution fees
267.1 93.4 4.9 10.0 0.1 375.5 
Shareholder servicing fees
55.1 8.0 0.4 — — 63.5 
Other
13.1 — 0.2 — — 13.3 
Total
$1,696.7 $325.3 $81.3 $63.6 $84.7 $2,251.6 
(in millions)United StatesLuxembourgAsia-PacificAmericas
Excluding
United
States
Europe,
Middle East
and Africa,
Excluding
Luxembourg
Total
for the three months ended December 31, 2023
Investment management fees
$1,260.6 $191.7 $68.5 $51.5 $79.9 $1,652.2 
Sales and distribution fees
205.7 76.5 4.6 9.6 — 296.4 
Shareholder servicing fees
24.2 7.6 0.6 0.1 — 32.5 
Other
9.0 0.5 0.2 — 0.3 10.0 
Total
$1,499.5 $276.3 $73.9 $61.2 $80.2 $1,991.1 
v3.24.4
Investments (Tables)
3 Months Ended
Dec. 31, 2024
Investments [Abstract]  
Summary of investments
Investments consisted of the following:
(in millions)December 31,
2024
September 30,
2024
Investments, at fair value
Sponsored funds and separate accounts$469.1 $509.1 
Investments related to long-term incentive plans266.3 271.6 
Other equity and debt investments71.5 57.3 
Total investments, at fair value806.9 838.0 
Investments in equity method investees1,175.5 1,219.7 
Other investments410.1 280.7 
Total$2,392.5 $2,338.4 
v3.24.4
Fair Value Measurements (Tables)
3 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities measured at fair value on a recurring basis
The assets and liabilities measured at fair value on a recurring basis were as follows: 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of December 31, 2024
Assets
Investments, at fair value
Sponsored funds and separate accounts$257.6 $171.3 $4.7 $35.5 $469.1 
Investments related to long-term incentive plans237.1 — — 29.2 266.3 
Other equity and debt investments17.5 14.0 1.6 38.4 71.5 
Total Assets Measured at Fair Value$512.2 $185.3 $6.3 $103.1 $806.9 
Liabilities
Securities sold short$244.9 $— $— $— $244.9 
Contingent consideration liabilities— — 27.5 — 27.5 
Total Liabilities Measured at Fair Value$244.9 $ $27.5 $ $272.4 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of September 30, 2024
Assets
Investments, at fair value
Sponsored funds and separate accounts$306.3 $157.4 $5.2 $40.2 $509.1 
Investments related to long-term incentive plans242.5 — — 29.1 271.6 
Other equity and debt investments4.1 11.1 2.6 39.5 57.3 
Total Assets Measured at Fair Value$552.9 $168.5 $7.8 $108.8 $838.0 
Liabilities
Securities sold short$178.1 $— $— $— $178.1 
Contingent consideration liabilities— — 28.2 — 28.2 
Total Liabilities Measured at Fair Value$178.1 $ $28.2 $ $206.3 
Schedule of investments measured at NAV
Investments for which fair value was estimated using reported NAV as a practical expedient primarily consist of nonredeemable private equity, debt and infrastructure funds, and redeemable alternative credit, global equity, private real estate funds and alternatives. These investments were as follows:
(in millions)December 31,
2024
September 30,
2024
Nonredeemable investments1
Investments with known liquidation periods$29.7 $32.4 
Investments with unknown liquidation periods15.7 16.1 
Redeemable investments2
57.7 60.3 
Unfunded commitments15.6 14.0 
Schedule of financial instruments not measured at fair value
Financial instruments that were not measured at fair value were as follows:
(in millions)Fair Value
Level
December 31, 2024September 30, 2024
Carrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
Financial Assets
Cash and cash equivalents1$2,808.0 $2,808.0 $3,309.5 $3,309.5 
Other investments
Time deposits28.7 8.7 9.8 9.8 
Equity securities3401.4 401.4 270.9 270.9 
Financial Liability
Debt2$2,775.8 $2,315.0 $2,780.3 $2,387.0 
v3.24.4
Consolidated Investment Products (Tables)
3 Months Ended
Dec. 31, 2024
Consolidated Investment Products [Abstract]  
Schedule of balances of CIPs
The balances related to CIPs included in the Company’s consolidated balance sheets were as follows:
(in millions)December 31,
2024
September 30,
2024
Assets
Cash and cash equivalents$837.1 $1,099.4 
Receivables141.5 217.5 
Investments, at fair value11,897.4 11,034.9 
Total Assets$12,876.0 $12,351.8 
Liabilities
Accounts payable and accrued expenses$861.2 $861.3 
Debt9,055.3 9,341.5 
Other liabilities11.2 39.9 
Total liabilities9,927.7 10,242.7 
Redeemable Noncontrolling Interests1,466.5 687.8 
Stockholders Equity
Franklin Resources, Inc.’s interests1,098.0 1,080.9 
Nonredeemable noncontrolling interests383.8 340.4 
Total stockholders’ equity1,481.8 1,421.3 
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders Equity
$12,876.0 $12,351.8 
Schedule of assets measured at fair value on a recurring basis
Assets of CIPs measured at fair value on a recurring basis were as follows: 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of December 31, 2024
Assets
Cash and cash equivalents of CLOs$519.3 $— $— $— $519.3 
Receivables of CLOs— 80.8 — — 80.8 
Investments
Equity and debt securities485.5 1,501.9 573.5 124.0 2,684.9 
Loans— 9,212.3 0.2 — 9,212.5 
Total Assets Measured at Fair Value$1,004.8 $10,795.0 $573.7 $124.0 $12,497.5 
(in millions)Level 1Level 2Level 3NAV as a
Practical
Expedient
Total
as of September 30, 2024
Assets
Cash and cash equivalents of CLOs$764.3 $— $— $— $764.3 
Receivables of CLOs— 149.6 — — 149.6 
Investments
Equity and debt securities229.7 889.4 550.1 187.1 1,856.3 
Loans— 9,178.1 0.5 — 9,178.6 
Total Assets Measured at Fair Value$994.0 $10,217.1 $550.6 $187.1 $11,948.8 
Schedule of CIPs investments measured at NAV
Investments for which fair value was estimated using reported NAV as a practical expedient consist of a redeemable U.S. equity fund, a redeemable global hedge fund and nonredeemable private debt funds. These investments were as follows:
(in millions)December 31,
2024
September 30,
2024
Nonredeemable investments1
Investments with unknown liquidation periods$53.8 $49.0 
Redeemable investments2
70.2 138.1 
Unfunded commitments3
42.8 42.8 
Schedule of changes in Level 3 assets of CIPs
Changes in Level 3 assets were as follows: 
(in millions)Equity and Debt
Securities
for the three months ended December 31, 2024
Balance at October 1, 2024$550.1 
Gains included in investment and other income (losses) of consolidated investment products, net22.0 
Purchases9.2 
Sales
(11.6)
Net consolidations3.8 
Balance at December 31, 2024$573.5 
Change in unrealized gains included in net income relating to assets held at December 31, 2024$22.3 
(in millions)Equity and Debt
Securities
LoansTotal 
Level 3
Assets
for the three months ended December 31, 2023
Balance at October 1, 2023$584.9 $— $584.9 
Losses included in investment and other income (losses) of consolidated investment products, net(38.1)— (38.1)
Purchases3.8 — 3.8 
Sales
(0.2)— (0.2)
Transfers into Level 31.1 0.6 1.7 
Balance at December 31, 2023$551.5 $0.6 $552.1 
Change in unrealized losses included in net income relating to assets held at December 31, 2023$(37.8)$— $(37.8)
Schedule of valuation techniques and significant unobservable inputs used in Level 3 fair value measurements
Valuation techniques and significant unobservable inputs used in Level 3 fair value measurements were as follows:
(in millions)
as of December 31, 2024Fair ValueValuation TechniqueSignificant Unobservable Inputs
Range (Weighted Average1)
Equity and debt securities$302.2 Market comparable companiesEnterprise value/ Revenue multiple
1.4–28.7 (11.0)
Discount for lack of marketability
5.8%–11.8% (8.0%)
219.1 Market pricingPrivate sale pricing
$0.01–$1,120.00 ($82.93) per share
Discount for lack of marketability
9.7%–13.3% (10.4%)
52.2 Discounted cash flowDiscount rate
6.3%–6.4% (6.3%)
(in millions)
as of September 30, 2024Fair ValueValuation TechniqueSignificant Unobservable Inputs
Range (Weighted Average1)
Equity and debt securities$291.6 Market comparable companiesEnterprise value/ Revenue multiple
1.2–22.8 (10.9)
Discount for lack of marketability
0.1%–10.4% (8.1%)
214.5 Market pricingPrivate sale pricing
$0.01–$1,000.00 ($73.04) per share
Discount for lack of marketability
9.8%–17.5% (11.5%)
44.0 Discounted cash flowDiscount rate6.8%
Schedule of financial instruments of CIPs not measured at fair value
Financial instruments of CIPs that were not measured at fair value were as follows:
(in millions)Fair Value
Level
December 31, 2024September 30, 2024
Carrying
Value
Estimated
Fair Value
Carrying
Value
Estimated
Fair Value
Financial Asset
Cash and cash equivalents1$317.8 $317.8 $335.1 $335.1 
Financial Liabilities
Debt of CLOs1
2 or 3$9,055.3 $8,858.1 $9,341.5 $9,167.3 
Schedule of contractual maturities for debt of CIPs
The contractual maturities for the debt of CLOs at December 31, 2024 were as follows:
(in millions)
for the fiscal years ending September 30,Amount
2025 (remainder of year)$120.1 
2026— 
2027— 
2028— 
2029— 
Thereafter8,935.2 
Total$9,055.3 
Schedule of unpaid principal balance and fair value of investments of CLOs
The unpaid principal balance and fair value of the investments of CLOs were as follows:
(in millions)December 31,
2024
September 30,
2024
Unpaid principal balance$9,420.8 $9,371.9 
Difference between unpaid principal balance and fair value(24.1)(19.8)
Fair Value$9,396.7 $9,352.1 
v3.24.4
Redeemable Noncontrolling Interests (Tables)
3 Months Ended
Dec. 31, 2024
Noncontrolling Interest [Abstract]  
Schedule of changes in redeemable noncontrolling interests of CIPs
Changes in redeemable noncontrolling interests were as follows:
(in millions)20242023
CIPsMinority InterestsTotalCIPsMinority InterestsTotal
for the three months ended December 31,
Balance at beginning of period$687.8 $634.0 $1,321.8 $580.1 $446.0 $1,026.1 
Net income (loss)38.9 10.7 49.6 (2.9)12.4 9.5 
Net subscriptions (distributions) and other175.6 (3.7)171.9 38.1 (1.1)37.0 
Net consolidations (deconsolidations)564.2 — 564.2 (60.0)— (60.0)
Adjustment to fair value— (1.5)(1.5)— 65.9 65.9 
Balance at End of Period$1,466.5 $639.5 $2,106.0 $555.3 $523.2 $1,078.5 
v3.24.4
Nonconsolidated Variable Interest Entities (Tables)
3 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of maximum exposure to loss from nonconsolidated VIEs The Company’s maximum exposure to loss from these VIEs consists of equity investments, investment management and other fee receivables as follows: 
(in millions)December 31,
2024
September 30,
2024
Investments$1,106.8 $1,074.4 
Receivables219.8 226.0 
Total$1,326.6 $1,300.4 
v3.24.4
Stock-Based Compensation (Tables)
3 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Summary of stock and stock unit award activity
Stock and stock unit award activity was as follows:
(shares in thousands)Time-Based
Shares
Performance-
Based Shares
Total
Shares
Weighted-
Average
Grant-Date
Fair Value
for the three months ended December 31, 2024
Nonvested balance at October 1, 202416,594 3,314 19,908 $24.03 
Granted7,812 169 7,981 20.73 
Vested(524)(166)(690)26.34 
Forfeited/canceled(226)(72)(298)24.95 
Nonvested Balance at December 31, 202423,656 3,245 26,901 $22.98 
v3.24.4
Investment and Other Income, Net (Tables)
3 Months Ended
Dec. 31, 2024
Other Income and Expenses [Abstract]  
Schedule of investment and other income (losses), net
Investment and other income, net consisted of the following:
 
Three Months Ended
December 31,
(in millions)20242023
Dividend and interest income$43.1 $54.8 
Gains (losses) on investments, net(57.1)60.1 
Income (losses) from investments in equity method investees(7.6)56.9 
Gains (losses) on derivatives, net6.6 (8.2)
Rental income11.2 10.8 
Foreign currency exchange gains (losses), net14.5 (7.4)
Other, net(0.2)6.2 
Investment and other income, net$10.5 $173.2 
v3.24.4
Earnings per Share - Components of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Earnings Per Share Reconciliation [Abstract]    
Net income attributable to Franklin Resources, Inc. $ 163.6 $ 251.3
Less: allocation of earnings to participating nonvested stock and stock unit awards - basic 15.4 9.7
Less: allocation of earnings to participating nonvested stock and stock unit awards - diluted 15.4 9.7
Net Income Available to Common Stockholders - basic 148.2 241.6
Net Income Available to Common Stockholders - diluted $ 148.2 $ 241.6
Weighted-average shares outstanding – basic 517.4 487.0
Dilutive effect of nonparticipating nonvested stock unit awards 0.8 0.9
Weighted-Average Shares Outstanding – Diluted 518.2 487.9
Earnings per Share [Abstract]    
Basic $ 0.29 $ 0.50
Diluted $ 0.29 $ 0.50
v3.24.4
Revenues Narratives (Details)
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]    
Revenue From Sponsored Funds 83.00% 83.00%
v3.24.4
Revenues - Schedule of Operating Revenues by Geographic Area (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area $ 2,251.6 $ 1,991.1
Investment management fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 1,799.3 1,652.2
Sales and distribution fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 375.5 296.4
Shareholder servicing fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 63.5 32.5
Other [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 13.3 10.0
United States [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 1,696.7 1,499.5
United States [Member] | Investment management fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 1,361.4 1,260.6
United States [Member] | Sales and distribution fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 267.1 205.7
United States [Member] | Shareholder servicing fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 55.1 24.2
United States [Member] | Other [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 13.1 9.0
Luxembourg [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 325.3 276.3
Luxembourg [Member] | Investment management fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 223.9 191.7
Luxembourg [Member] | Sales and distribution fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 93.4 76.5
Luxembourg [Member] | Shareholder servicing fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 8.0 7.6
Luxembourg [Member] | Other [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 0.0 0.5
Asia-Pacific [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 81.3 73.9
Asia-Pacific [Member] | Investment management fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 75.8 68.5
Asia-Pacific [Member] | Sales and distribution fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 4.9 4.6
Asia-Pacific [Member] | Shareholder servicing fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 0.4 0.6
Asia-Pacific [Member] | Other [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 0.2 0.2
Americas Excluding United States [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 63.6 61.2
Americas Excluding United States [Member] | Investment management fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 53.6 51.5
Americas Excluding United States [Member] | Sales and distribution fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 10.0 9.6
Americas Excluding United States [Member] | Shareholder servicing fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 0.0 0.1
Americas Excluding United States [Member] | Other [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 0.0 0.0
Europe, Middle East and Africa, Excluding Luxembourg [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 84.7 80.2
Europe, Middle East and Africa, Excluding Luxembourg [Member] | Investment management fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 84.6 79.9
Europe, Middle East and Africa, Excluding Luxembourg [Member] | Sales and distribution fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 0.1 0.0
Europe, Middle East and Africa, Excluding Luxembourg [Member] | Shareholder servicing fees [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area 0.0 0.0
Europe, Middle East and Africa, Excluding Luxembourg [Member] | Other [Member]    
Disaggregation of Revenue [Line Items]    
Operating revenues by geographic area $ 0.0 $ 0.3
v3.24.4
Investments - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Investments [Abstract]    
Securities Sold under Agreements to Repurchase $ 116.5 $ 111.4
Securities Borrowed, Fair Value of Collateral $ 122.5 $ 121.7
v3.24.4
Investments - Summary of Investments (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Investment Holdings [Line Items]    
Total investments, at fair value $ 806.9 $ 838.0
Investments in equity method investees 1,175.5 1,219.7
Other investments 410.1 280.7
Investments 2,392.5 2,338.4
Sponsored funds and separate accounts [Member]    
Investment Holdings [Line Items]    
Investments, at fair value 469.1 509.1
Investments related to long-term incentive plans [Member]    
Investment Holdings [Line Items]    
Investments, at fair value 266.3 271.6
Other equity and debt investments [Member]    
Investment Holdings [Line Items]    
Investments, at fair value $ 71.5 $ 57.3
v3.24.4
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Sponsored funds and separate accounts [Member]    
Assets [Abstract]    
Investments, at fair value $ 469.1 $ 509.1
Investments related to long-term incentive plans [Member]    
Assets [Abstract]    
Investments, at fair value 266.3 271.6
Other equity and debt investments [Member]    
Assets [Abstract]    
Investments, at fair value 71.5 57.3
Fair Value, Recurring [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 806.9 838.0
Liability [Abstract]    
Securities sold short 244.9 178.1
Contingent consideration liabilities 27.5 28.2
Total Liabilities Measured at Fair Value 272.4 206.3
Fair Value, Recurring [Member] | Level 1 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 512.2 552.9
Liability [Abstract]    
Securities sold short 244.9 178.1
Contingent consideration liabilities 0.0 0.0
Total Liabilities Measured at Fair Value 244.9 178.1
Fair Value, Recurring [Member] | Level 2 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 185.3 168.5
Liability [Abstract]    
Securities sold short 0.0 0.0
Contingent consideration liabilities 0.0 0.0
Total Liabilities Measured at Fair Value 0.0 0.0
Fair Value, Recurring [Member] | Level 3 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 6.3 7.8
Liability [Abstract]    
Securities sold short 0.0 0.0
Contingent consideration liabilities 27.5 28.2
Total Liabilities Measured at Fair Value 27.5 28.2
Fair Value, Recurring [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 103.1 108.8
Liability [Abstract]    
Securities sold short 0.0 0.0
Contingent consideration liabilities 0.0 0.0
Total Liabilities Measured at Fair Value 0.0 0.0
Fair Value, Recurring [Member] | Sponsored funds and separate accounts [Member]    
Assets [Abstract]    
Investments, at fair value 469.1 509.1
Fair Value, Recurring [Member] | Sponsored funds and separate accounts [Member] | Level 1 [Member]    
Assets [Abstract]    
Investments, at fair value 257.6 306.3
Fair Value, Recurring [Member] | Sponsored funds and separate accounts [Member] | Level 2 [Member]    
Assets [Abstract]    
Investments, at fair value 171.3 157.4
Fair Value, Recurring [Member] | Sponsored funds and separate accounts [Member] | Level 3 [Member]    
Assets [Abstract]    
Investments, at fair value 4.7 5.2
Fair Value, Recurring [Member] | Sponsored funds and separate accounts [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Investments, at fair value 35.5 40.2
Fair Value, Recurring [Member] | Investments related to long-term incentive plans [Member]    
Assets [Abstract]    
Investments, at fair value 266.3 271.6
Fair Value, Recurring [Member] | Investments related to long-term incentive plans [Member] | Level 1 [Member]    
Assets [Abstract]    
Investments, at fair value 237.1 242.5
Fair Value, Recurring [Member] | Investments related to long-term incentive plans [Member] | Level 2 [Member]    
Assets [Abstract]    
Investments, at fair value 0.0 0.0
Fair Value, Recurring [Member] | Investments related to long-term incentive plans [Member] | Level 3 [Member]    
Assets [Abstract]    
Investments, at fair value 0.0 0.0
Fair Value, Recurring [Member] | Investments related to long-term incentive plans [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Investments, at fair value 29.2 29.1
Fair Value, Recurring [Member] | Other equity and debt investments [Member]    
Assets [Abstract]    
Investments, at fair value 71.5 57.3
Fair Value, Recurring [Member] | Other equity and debt investments [Member] | Level 1 [Member]    
Assets [Abstract]    
Investments, at fair value 17.5 4.1
Fair Value, Recurring [Member] | Other equity and debt investments [Member] | Level 2 [Member]    
Assets [Abstract]    
Investments, at fair value 14.0 11.1
Fair Value, Recurring [Member] | Other equity and debt investments [Member] | Level 3 [Member]    
Assets [Abstract]    
Investments, at fair value 1.6 2.6
Fair Value, Recurring [Member] | Other equity and debt investments [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Investments, at fair value $ 38.4 $ 39.5
v3.24.4
Fair Value Measurements - Schedule of investments measured at NAV (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Unfunded commitments $ 15.6 $ 14.0
Nonredeemable investments with unknown liquidation periods    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Alternative Investment [1] 15.7 16.1
Nonredeemable investments with known liquidation periods    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Alternative Investment [1] $ 29.7 $ 32.4
Liquidation weighted-average period 1 year 10 months 24 days 1 year 10 months 24 days
Redeemable Investments [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Alternative Investment [2] $ 57.7 $ 60.3
[1] The investments are expected to be returned through distributions over the life of the funds as a result of liquidations of the funds’ underlying assets. Investments with known liquidation periods have an expected weighted-average life of 1.9 years at December 31, 2024 and September 30, 2024.
[2] Investments are redeemable on a semi-monthly, monthly and quarterly basis.
v3.24.4
Fair Value Measurements - Schedule of Financial Instruments not Measured at Fair Value (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Financial Assets [Abstract]    
Other investments $ 410.1 $ 280.7
Financial Liability [Abstract]    
Debt 2,775.8 2,780.3
Carrying Value [Member]    
Financial Assets [Abstract]    
Cash and cash equivalents 2,808.0 3,309.5
Time deposits 8.7 9.8
Financial Liability [Abstract]    
Debt 2,775.8 2,780.3
Estimated Fair Value [Member] | Level 1 [Member]    
Financial Assets [Abstract]    
Cash and cash equivalents 2,808.0 3,309.5
Estimated Fair Value [Member] | Level 2 [Member]    
Financial Assets [Abstract]    
Time deposits 8.7 9.8
Financial Liability [Abstract]    
Debt 2,315.0 2,387.0
Equity securities [Member] | Carrying Value [Member]    
Financial Assets [Abstract]    
Other investments 401.4 270.9
Equity securities [Member] | Estimated Fair Value [Member] | Level 3 [Member]    
Financial Assets [Abstract]    
Other investments $ 401.4 $ 270.9
v3.24.4
Consolidated Investment Products - Narrative (Details)
$ in Millions
3 Months Ended
Dec. 31, 2024
USD ($)
CIPs
Dec. 31, 2023
USD ($)
Sep. 30, 2024
USD ($)
CIPs
Consolidated Investment Products [Abstract]      
Number of consolidated investment products | CIPs 75   77
Number of CLOs | CIPs 22   22
Schedule Of Consolidated Investment Products [Line Items]      
Debt $ 2,775.8   $ 2,780.3
CIPs [Member]      
Schedule Of Consolidated Investment Products [Line Items]      
Debt 9,055.3   9,341.5
Unfunded Commitments Company Contractually Obligated To Fund Consolidated Investment Products 9.9   9.9
Collateralized loan obligations [Member]      
Schedule Of Consolidated Investment Products [Line Items]      
Net gains related to its own economic interests. 11.7 $ 20.8  
Debt, unpaid principal balance 9,015.0   9,282.8
Collateralized loan obligations [Member] | CIPs [Member]      
Schedule Of Consolidated Investment Products [Line Items]      
Debt $ 9,055.3   $ 9,341.5
Effective interest rate 7.30%   7.36%
Collateralized loan obligations [Member] | CIPs [Member] | Minimum [Member]      
Schedule Of Consolidated Investment Products [Line Items]      
Stated interest rate 2.39%   2.39%
Collateralized loan obligations [Member] | CIPs [Member] | Maximum [Member]      
Schedule Of Consolidated Investment Products [Line Items]      
Stated interest rate 13.68%   13.73%
v3.24.4
Consolidated Investment Products - Schedule of Balances of CIPs (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Assets [Abstract]        
Receivables $ 1,393.8 $ 1,479.1    
Investments, at fair value 806.9 838.0    
Total Assets 32,390.0 32,464.5    
Liabilities [Abstract]        
Accounts payable and accrued expenses 585.0 551.5    
Debt 2,775.8 2,780.3    
Other liabilities 953.8 907.4    
Total liabilities 17,050.3 17,899.7    
Redeemable Noncontrolling Interests 2,106.0 1,321.8    
Stockholders' Equity [Abstract]        
Franklin Resources, Inc.’s interests 12,462.1 12,508.1    
Nonredeemable noncontrolling interests 771.6 734.9    
Total stockholders’ equity 13,233.7 13,243.0 $ 12,637.6 $ 12,547.8
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity 32,390.0 32,464.5    
CIPs [Member]        
Assets [Abstract]        
Cash and cash equivalents 837.1 1,099.4    
Receivables 141.5 217.5    
Investments, at fair value 11,897.4 11,034.9    
Total Assets 12,876.0 12,351.8    
Liabilities [Abstract]        
Accounts payable and accrued expenses 861.2 861.3    
Debt 9,055.3 9,341.5    
Other liabilities 11.2 39.9    
Total liabilities 9,927.7 10,242.7    
Redeemable Noncontrolling Interests 1,466.5 687.8 $ 555.3 $ 580.1
Stockholders' Equity [Abstract]        
Franklin Resources, Inc.’s interests 1,098.0 1,080.9    
Nonredeemable noncontrolling interests 383.8 340.4    
Total stockholders’ equity 1,481.8 1,421.3    
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity $ 12,876.0 $ 12,351.8    
v3.24.4
Consolidated Investment Products - Schedule of Balances of Assets and Liabilities of CIPs Measured at Fair Value (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Assets [Abstract]    
Investments, at fair value $ 806.9 $ 838.0
CIPs [Member]    
Assets [Abstract]    
Investments, at fair value 11,897.4 11,034.9
Fair Value, Recurring [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 806.9 838.0
Fair Value, Recurring [Member] | Level 1 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 512.2 552.9
Fair Value, Recurring [Member] | Level 2 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 185.3 168.5
Fair Value, Recurring [Member] | Level 3 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 6.3 7.8
Fair Value, Recurring [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 103.1 108.8
Fair Value, Recurring [Member] | CIPs [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 12,497.5 11,948.8
Fair Value, Recurring [Member] | CIPs [Member] | Level 1 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 1,004.8 994.0
Fair Value, Recurring [Member] | CIPs [Member] | Level 2 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 10,795.0 10,217.1
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 573.7 550.6
Fair Value, Recurring [Member] | CIPs [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Total Assets Measured at Fair Value 124.0 187.1
Equity and debt securities [Member] | Fair Value, Recurring [Member] | CIPs [Member]    
Assets [Abstract]    
Investments, at fair value 2,684.9 1,856.3
Equity and debt securities [Member] | Fair Value, Recurring [Member] | CIPs [Member] | Level 1 [Member]    
Assets [Abstract]    
Investments, at fair value 485.5 229.7
Equity and debt securities [Member] | Fair Value, Recurring [Member] | CIPs [Member] | Level 2 [Member]    
Assets [Abstract]    
Investments, at fair value 1,501.9 889.4
Equity and debt securities [Member] | Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member]    
Assets [Abstract]    
Investments, at fair value 573.5 550.1
Equity and debt securities [Member] | Fair Value, Recurring [Member] | CIPs [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Investments, at fair value 124.0 187.1
Loans [Member] | Fair Value, Recurring [Member] | CIPs [Member]    
Assets [Abstract]    
Investments, at fair value 9,212.5 9,178.6
Loans [Member] | Fair Value, Recurring [Member] | CIPs [Member] | Level 1 [Member]    
Assets [Abstract]    
Investments, at fair value 0.0 0.0
Loans [Member] | Fair Value, Recurring [Member] | CIPs [Member] | Level 2 [Member]    
Assets [Abstract]    
Investments, at fair value 9,212.3 9,178.1
Loans [Member] | Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member]    
Assets [Abstract]    
Investments, at fair value 0.2 0.5
Loans [Member] | Fair Value, Recurring [Member] | CIPs [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Investments, at fair value 0.0 0.0
Collateralized loan obligations [Member]    
Assets [Abstract]    
Investments, at fair value 9,396.7 9,352.1
Collateralized loan obligations [Member] | Fair Value, Recurring [Member]    
Assets [Abstract]    
Cash and cash equivalents of CLOs 519.3 764.3
Receivables of CLOs 80.8 149.6
Collateralized loan obligations [Member] | Fair Value, Recurring [Member] | Level 1 [Member]    
Assets [Abstract]    
Cash and cash equivalents of CLOs 519.3 764.3
Receivables of CLOs 0.0 0.0
Collateralized loan obligations [Member] | Fair Value, Recurring [Member] | Level 2 [Member]    
Assets [Abstract]    
Cash and cash equivalents of CLOs 0.0 0.0
Receivables of CLOs 80.8 149.6
Collateralized loan obligations [Member] | Fair Value, Recurring [Member] | Level 3 [Member]    
Assets [Abstract]    
Cash and cash equivalents of CLOs 0.0 0.0
Receivables of CLOs 0.0 0.0
Collateralized loan obligations [Member] | Fair Value, Recurring [Member] | NAV as a Practical Expedient [Member]    
Assets [Abstract]    
Cash and cash equivalents of CLOs 0.0 0.0
Receivables of CLOs $ 0.0 $ 0.0
v3.24.4
Consolidated Investment Products - Schedule of Investments measured at NAV (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Schedule Of Consolidated Investment Products [Line Items]    
Unfunded commitments $ 15.6 $ 14.0
Nonredeemable investments with known liquidation periods    
Schedule Of Consolidated Investment Products [Line Items]    
Alternative Investment [1] 29.7 32.4
Nonredeemable investments with unknown liquidation periods    
Schedule Of Consolidated Investment Products [Line Items]    
Alternative Investment [1] 15.7 16.1
Redeemable Funds    
Schedule Of Consolidated Investment Products [Line Items]    
Alternative Investment [2] 57.7 60.3
CIPs [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Unfunded commitments 42.8 [3],[4],[5] 42.8
CIPs [Member] | Nonredeemable investments with unknown liquidation periods    
Schedule Of Consolidated Investment Products [Line Items]    
Alternative Investment 53.8 49.0
CIPs [Member] | Redeemable Funds    
Schedule Of Consolidated Investment Products [Line Items]    
Alternative Investment $ 70.2 $ 138.1
[1] The investments are expected to be returned through distributions over the life of the funds as a result of liquidations of the funds’ underlying assets. Investments with known liquidation periods have an expected weighted-average life of 1.9 years at December 31, 2024 and September 30, 2024.
[2] Investments are redeemable on a semi-monthly, monthly and quarterly basis.
[3] Investments are redeemable on a monthly basis and liquidation periods are unknown.
[4] Of the total unfunded commitments, the Company was contractually obligated to fund $9.9 million based on its ownership percentage in the CIPs, at December 31, 2024 and September 30, 2024.
[5] The investments are expected to be returned through distributions over the life of the funds as a result of liquidations of the funds’ underlying assets.
v3.24.4
Consolidated Investment Products - Schedule of Changes in Level 3 Assets of CIPs (Details) - CIPs [Member] - Level 3 [Member] - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Schedule Of Consolidated Investment Products [Line Items]    
Balance at beginning of period - assets   $ 584.9
Gains included in investment and other income (losses) of consolidated investment products, net   (38.1)
Purchases   3.8
Sales   (0.2)
Transfers Into Level 3   1.7
Balance at End of Period - assets   552.1
Change in unrealized gains included in net income relating to assets held at December 31, 2024   (37.8)
Equity and debt securities [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Balance at beginning of period - assets $ 550.1 584.9
Gains included in investment and other income (losses) of consolidated investment products, net 22.0 (38.1)
Purchases 9.2 3.8
Sales (11.6) (0.2)
Net consolidations/ (deconsolidations) 3.8  
Transfers Into Level 3   1.1
Balance at End of Period - assets 573.5 551.5
Change in unrealized gains included in net income relating to assets held at December 31, 2024 $ 22.3 (37.8)
Loans [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Balance at beginning of period - assets   0.0
Gains included in investment and other income (losses) of consolidated investment products, net   0.0
Purchases   0.0
Sales   0.0
Transfers Into Level 3   0.6
Balance at End of Period - assets   0.6
Change in unrealized gains included in net income relating to assets held at December 31, 2024   $ 0.0
v3.24.4
Consolidated Investment Products - Schedule of Valuation Techniques and Significant Unobservable Inputs used in Level 3 Fair Value Measurements (Details)
$ in Millions
Dec. 31, 2024
USD ($)
$ / shares
Sep. 30, 2024
USD ($)
$ / shares
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value $ 806.9 $ 838.0
CIPs [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value 11,897.4 11,034.9
Fair Value, Recurring [Member] | CIPs [Member] | Equity and debt securities [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value 2,684.9 1,856.3
Fair Value, Recurring [Member] | CIPs [Member] | Loans [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value 9,212.5 9,178.6
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value 573.5 550.1
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market pricing [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value $ 219.1 $ 214.5
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market pricing [Member] | Private sale pricing [Member] | Minimum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input | $ / shares 0.01 0.01
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market pricing [Member] | Private sale pricing [Member] | Maximum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input | $ / shares 1,120 1,000
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market pricing [Member] | Private sale pricing [Member] | Weighted Average [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input | $ / shares 82.93 [1] 73.04
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market pricing [Member] | Discount for lack of marketability [Member] | Minimum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.097 0.098
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market pricing [Member] | Discount for lack of marketability [Member] | Maximum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.133 0.175
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market pricing [Member] | Discount for lack of marketability [Member] | Weighted Average [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.104 0.115
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market comparable companies [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value $ 302.2 $ 291.6
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market comparable companies [Member] | Discount for lack of marketability [Member] | Minimum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.058 0.001
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market comparable companies [Member] | Discount for lack of marketability [Member] | Maximum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.118 0.104
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market comparable companies [Member] | Discount for lack of marketability [Member] | Weighted Average [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.080 0.081
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market comparable companies [Member] | Revenue multiple [Member] | Minimum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 1.4 1.2
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market comparable companies [Member] | Revenue multiple [Member] | Maximum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 28.7 22.8
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Market comparable companies [Member] | Revenue multiple [Member] | Weighted Average [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 11.0 10.9
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Discounted cash flow [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value $ 52.2 $ 44.0
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Discounted cash flow [Member] | Discount rate [Member] | Minimum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.063  
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Discounted cash flow [Member] | Discount rate [Member] | Maximum [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.064  
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Equity and debt securities [Member] | Discounted cash flow [Member] | Discount rate [Member] | Weighted Average [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Investments, measurement input 0.063 0.068 [1]
Fair Value, Recurring [Member] | CIPs [Member] | Level 3 [Member] | Loans [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Total investments, at fair value $ 0.2 $ 0.5
[1] Based on the relative fair value of the instruments.
v3.24.4
Consolidated Investment Products - Schedule of Financial Instruments of CIPs not Measured at Fair Value (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Carrying Value [Member]    
Financial Assets [Abstract]    
Cash and cash equivalents $ 2,808.0 $ 3,309.5
Financial Liability [Abstract]    
Debt of CLOs1 2,775.8 2,780.3
Carrying Value [Member] | CIPs [Member]    
Financial Assets [Abstract]    
Cash and cash equivalents 317.8 335.1
Estimated Fair Value [Member] | Level 1 [Member]    
Financial Assets [Abstract]    
Cash and cash equivalents 2,808.0 3,309.5
Estimated Fair Value [Member] | Level 2 [Member]    
Financial Liability [Abstract]    
Debt of CLOs1 2,315.0 2,387.0
Estimated Fair Value [Member] | CIPs [Member] | Level 1 [Member]    
Financial Assets [Abstract]    
Cash and cash equivalents 317.8 335.1
Receivables 1,393.8 1,479.1
Financial Liability [Abstract]    
Debt of CLOs1 2,775.8 2,780.3
CIPs [Member]    
Financial Assets [Abstract]    
Cash and cash equivalents 837.1 1,099.4
Receivables 141.5 217.5
Financial Liability [Abstract]    
Debt of CLOs1 9,055.3 9,341.5
Collateralized loan obligations [Member] | Carrying Value [Member] | CIPs [Member]    
Financial Liability [Abstract]    
Debt of CLOs1 [1] 9,055.3 9,341.5
Collateralized loan obligations [Member] | Estimated Fair Value [Member] | CIPs [Member] | Level 2 [Member]    
Financial Liability [Abstract]    
Debt of CLOs1 [1] 8,858.1 9,167.3
Collateralized loan obligations [Member] | CIPs [Member]    
Financial Liability [Abstract]    
Debt of CLOs1 $ 9,055.3 $ 9,341.5
[1] Substantially all was Level 2.
v3.24.4
Consolidated Investment Products - Schedule of Contractual Maturities for Debt of CIPs (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Schedule Of Consolidated Investment Products [Line Items]    
Total $ 2,775.8 $ 2,780.3
CIPs [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
2025 (remainder of year) 120.1  
2023 0.0  
2024 0.0  
2025 0.0  
2026 0.0  
Thereafter 8,935.2  
Total $ 9,055.3  
v3.24.4
Consolidated Investment Products - Schedule of Unpaid Principal Balance and Fair Value of Investments (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Schedule Of Consolidated Investment Products [Line Items]    
Unpaid principal balance $ 2,392.5 $ 2,338.4
Total investments, at fair value 806.9 838.0
Collateralized loan obligations [Member]    
Schedule Of Consolidated Investment Products [Line Items]    
Unpaid principal balance 9,420.8 9,371.9
Difference between unpaid principal balance and fair value (24.1) (19.8)
Total investments, at fair value $ 9,396.7 $ 9,352.1
v3.24.4
Redeemable Noncontrolling Interests (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Noncontrolling Interest [Line Items]    
Balance at beginning of period $ 1,321.8  
Net income (loss) 49.6 $ 9.5
Net subscriptions (distributions) and other 13.1 9.6
Net consolidations (deconsolidations) 4.7  
Adjustment to fair value 1.5 (65.9)
Balance at End of Period 2,106.0  
Minority Interests [Member]    
Noncontrolling Interest [Line Items]    
Balance at beginning of period 634.0 446.0
Net income (loss) 10.7 12.4
Net subscriptions (distributions) and other (3.7) (1.1)
Net consolidations (deconsolidations) 0.0 0.0
Adjustment to fair value (1.5) 65.9
Balance at End of Period 639.5 523.2
Redeemable Noncontrolling Interests [Member]    
Noncontrolling Interest [Line Items]    
Balance at beginning of period 1,321.8 1,026.1
Net income (loss) 49.6 9.5
Net subscriptions (distributions) and other 171.9 37.0
Net consolidations (deconsolidations) 564.2 (60.0)
Adjustment to fair value (1.5) 65.9
Balance at End of Period 2,106.0 1,078.5
Retained Earnings [Member]    
Noncontrolling Interest [Line Items]    
Adjustment to fair value 1.5 (65.9)
CIPs [Member]    
Noncontrolling Interest [Line Items]    
Balance at beginning of period 687.8 580.1
Net income (loss) 38.9 (2.9)
Net subscriptions (distributions) and other 175.6 38.1
Net consolidations (deconsolidations) 564.2 (60.0)
Adjustment to fair value 0.0 0.0
Balance at End of Period $ 1,466.5 $ 555.3
v3.24.4
Nonconsolidated Variable Interest Entities - Schedule of Maximum Exposure to Loss (Details) - Variable Interest Entity, Not Primary Beneficiary - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Variable Interest Entity [Line Items]    
Maximum exposure to loss $ 1,326.6 $ 1,300.4
Investments [Member]    
Variable Interest Entity [Line Items]    
Maximum exposure to loss 1,106.8 1,074.4
Receivables [Member]    
Variable Interest Entity [Line Items]    
Maximum exposure to loss $ 219.8 $ 226.0
v3.24.4
Stock-Based Compensation - Narrative (Details)
$ in Millions
3 Months Ended
Dec. 31, 2024
USD ($)
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Unrecognized compensation expense related to nonvested stock and stock unit awards $ 310.4
Remaining weighted-average vesting period 2 years 1 month 6 days
v3.24.4
Stock-Based Compensation - Summary of Stock and Stock Unit Award Activity (Details)
shares in Thousands
3 Months Ended
Dec. 31, 2024
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Nonvested balance at October 1, 2024 19,908
Granted 7,981
Vested (690)
Forfeited/canceled (298)
Nonvested Balance at December 31, 2024 26,901
Nonvested beginning balance, Weighted Average Grant Date Fair Value | $ / shares $ 24.03
Weighted Average Grant Date Fair Value of shares granted | $ / shares 20.73
Weighted Average Grant Date Fair Value of shares vested | $ / shares 26.34
Weighted Average Grant Date Fair Value of shares forfeited/canceled | $ / shares 24.95
Nonvested ending balance, Weighted Average Grant Date Fair Value | $ / shares $ 22.98
Time-Based Shares [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Nonvested balance at October 1, 2024 16,594
Granted 7,812
Vested (524)
Forfeited/canceled (226)
Nonvested Balance at December 31, 2024 23,656
Performance-Based Shares [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Nonvested balance at October 1, 2024 3,314
Granted 169
Vested (166)
Forfeited/canceled (72)
Nonvested Balance at December 31, 2024 3,245
v3.24.4
Investment and Other Income, net - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Other Income and Expenses [Abstract]    
Net gains (losses) recognized on equity securities measured at fair value and trading debt securities $ (87.2) $ 68.5
v3.24.4
Investment and Other Income , Net - Schedule of Investment and Other Income, Net (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Other Income and Expenses [Abstract]    
Dividend and interest income $ 43.1 $ 54.8
Gains (losses) on investments, net (57.1) 60.1
Income (losses) from investments in equity method investees (7.6) 56.9
Gains (losses) on derivatives, net 6.6 (8.2)
Rental income 11.2 10.8
Foreign currency exchange gains (losses), net 14.5 (7.4)
Other, net   6.2
Other, net (0.2)  
Investment and other income, net $ 10.5 $ 173.2

Franklin Resources (NYSE:BEN)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Franklin Resources Charts.
Franklin Resources (NYSE:BEN)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Franklin Resources Charts.